Benign leiomyoma with endometriosis

CD2_LEIOMYOMA_ENDOMETRIOSIS_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule only females	-
2. Check conditions N14_ENDOMETRIOSIS	-
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints CD2_BENIGN_LEIOMYOMA_UTERI	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE
Control conditions: not N14_ENDOMETRIOSIS

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF10

NAME	CD2_LEIOMYOMA_ENDOMETRIOSIS_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	!N14_ENDOMETRIOSIS
SEX	2
INCLUDE	CD2_BENIGN_LEIOMYOMA_UTERI
PRE_CONDITIONS
CONDITIONS	N14_ENDOMETRIOSIS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign leiomyoma with endometriosis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Benign leiomyoma with endometriosis

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6504	6504	-
Unadjusted period prevalence (%)	2.22	2.22	-
Median age at first event (years)	43.97	43.97	-

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5903: Matched controls
59029

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N80.0

ICD-10 Finland

Endometriosis of uterus

1126.2

323.0

1176

6170A

ICD-9 Finland

Endometriosis of uterus

+∞

323.0

514

62530

ICD-8 Finland

Other diseases of uterus, Endometriosis ovarii

+∞

323.0

579

PJA12

NOMESCO Finland

Sentinel node biopsy

418.8

323.0

394

2180A

ICD-9 Finland

Uterine leiomyoma, Submucous leiomyoma of uterus

7.7

323.0

1619

2753

62532

ICD-8 Finland

Other diseases of uterus, Endometriosis retro-cervicalis sive retrouterina

+∞

323.0

539

6171A

ICD-9 Finland

Endometriosis of ovary

+∞

323.0

660

115

Kela drug reimbursment

Breast cancer

+∞

323.0

465

6173B

ICD-9 Finland

Endometriosis of pelvic peritoneum[ENDOMETRIOSIS RETROUTERINA]

+∞

323.0

490

6173A

ICD-9 Finland

Endometriosis of pelvic peritoneum[ENDOMETRIOSIS SEROSAE PELVIS]

+∞

323.0

343

D25.9

ICD-10 Finland

Leiomyoma of uterus, unspecified

6.8

323.0

2014

4175

D25.1

ICD-10 Finland

Intramural leiomyoma of uterus

6.4

323.0

1345

2612

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

323.0

313

21899

ICD-8 Finland

Uterine fibroma

8.3

323.0

1224

1812

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

3836.5

323.0

999

N80.1

ICD-10 Finland

Endometriosis of ovary

4590.4

323.0

1154

N80.9

ICD-10 Finland

Endometriosis, unspecified

345.5

323.0

384

N80.4

ICD-10 Finland

Endometriosis of rectovaginal septum and vagina

+∞

320.7

305

62533

ICD-8 Finland

Other diseases of uterus, Adenomyosis uteri

+∞

317.6

302

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

264.5

252

H02AB02

ATC

dexamethasone; systemic

16.3

235.7

392

257

L02BG04

ATC

letrozole; oral

21.7

228.2

342

167

LCD00

NOMESCO Finland

Hysterectomy

5.1

228.0

788

1728

JAL21

NOMESCO Finland

Laparoscopic excision or destruction of lesion of peritoneum

71.7

216.0

248

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

5.6

215.9

680

1336

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

213.8

204

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

1028.0

204.3

199

HAC20

NOMESCO Finland

Total mastectomy

237.0

200.9

206

D25.0

ICD-10 Finland

Submucous leiomyoma of uterus

5.0

196.1

683

1498

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

641.6

190.0

187

A04AA02

ATC

granisetron; systemic, transdermal

98.0

188.5

208

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

+∞

184.3

176

130

Kela drug reimbursment

Malignant tumour

+∞

183.2

175

HAB40

NOMESCO Finland

Wedge excision of mammary gland

20.9

182.4

276

138

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

46.8

179.4

221

L02BA01

ATC

tamoxifen; oral

112.9

171.1

186

62531

ICD-8 Finland

Other diseases of uterus, Endometriosis serosae pelvis

+∞

167.5

160

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

97.7

163.1

180

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

2.3

161.5

4482

34409

8341

FHL

Colony removal or incineration

208.1

156.7

162

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

1514.6

149.6

145

L03AA13

ATC

pegfilgrastim; parenteral

1489.9

147.5

143

D25.2

ICD-10 Finland

Subserosal leiomyoma of uterus

6.4

145.3

405

672

8306

FHL

Hysterectomy (related to abortion 8516, prolapse correction 8436)

4.4

144.4

568

1395

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

3.0

144.4

953

3557

JAH01

NOMESCO Finland

Laparoscopy

5.1

136.3

464

979

C50.99

ICD-10 Finland

Breast, unspecified

662.7

132.1

130

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

2.7

129.4

1041

4371

62538

ICD-8 Finland

Other diseases of uterus, Endometriosis alia

+∞

127.5

122

1413

FHL

Laparoscopy and other therapeutic procedure

5.5

124.2

392

757

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

2.0

122.4

2247

13892

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

121.2

116

8201

FHL

Ovarian preservation exploration and related procedures, eg resection, enucleation or ovariolysis

7.6

121.2

297

409

LAF00

NOMESCO Finland

Unilateral salpingo-oophorectomy

10.2

119.8

245

249

HA1AA

NOMESCO Finland

X-ray mammography

4.3

118.4

469

1153

C50

ICD-10 Finland

Malignant neoplasm of breast

377.7

111.8

112

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

195.4

110.8

115

A03FA01

ATC

metoclopramide; systemic, rectal

2.4

109.0

1077

5011

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

542.7

108.1

107

121

Kela drug reimbursment

Severe hypofunction of sexual glands

7.1

108.0

276

404

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

106.6

102

N73.6

ICD-10 Finland

Female pelvic peritoneal adhesions

10.8

105.7

209

199

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

105.5

101

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.2

105.2

1282

6593

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

2.5

102.7

892

3865

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.6

102.6

382

880

LBF01

NOMESCO Finland

Laparoscopic perfusion of Fallopian tube

12.8

102.4

187

151

LAF01

NOMESCO Finland

Laparoscopic unilateral salpingo-oophorectomy

5.3

102.3

332

660

N80.8

ICD-10 Finland

Other endometriosis

+∞

101.3

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

336.0

99.3

100

WF003

NOMESCO Finland

Adjuvant radiotherapy

133.6

98.3

105

ZXE10

NOMESCO Finland

More than one and less than three hours

1.9

98.1

2164

13995

LCD01

NOMESCO Finland

Total laparoscopic hysterectomy

6.4

97.6

269

437

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

97.3

1495

8443

N80.5

ICD-10 Finland

Endometriosis of intestine

+∞

95.0

L01BC06

ATC

capecitabine; oral

+∞

95.0

A04AA55

ATC

palonosetron, combinations; systemic

922.6

93.1

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

7.7

89.7

216

289

B02AA02

ATC

tranexamic acid; systemic

2.1

89.4

1271

6919

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

87.7

LAC01

NOMESCO Finland

Laparoscopic excision of ovarian cyst

9.9

87.2

180

186

6178X

ICD-9 Finland

Endometriosis of other specified sites

+∞

86.7

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

86.7

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

4.0

86.2

367

959

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

52.4

85.7

103

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

85.6

6146A

ICD-9 Finland

Inflammatory disease of ovary, Fallopian tube, pelvic cellular tissue and peritoneum, Pelvic peritoneal adhesions, female

7.3

85.3

213

301

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

83.0

1471

8684

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

82.5

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

112.9

82.1

8308

FHL

Hysterectomy and bilateral adnexal removal

4.7

81.6

293

649

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

172.4

81.3

G03DC03

ATC

lynestrenol; oral

5.1

81.0

269

548

8204

FHL

Salpingo-oophorectomy

6.7

80.7

213

326

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

11.4

80.3

154

138

LAC21

NOMESCO Finland

Laparoscopic destruction of lesion of ovary

17.5

79.6

127

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

79.3

8307

FHL

Hysterectomy and unilateral removal of adhesions

7.0

78.7

202

297

N97.9

ICD-10 Finland

Female infertility, unspecified

3.8

78.7

357

985

N97.8

ICD-10 Finland

Female infertility of other origin

11.1

78.2

152

140

A04AD12

ATC

aprepitant; systemic

+∞

77.2

8305

FHL

Supravaginal amputation or resection

4.3

76.4

299

721

L02BG06

ATC

exemestane; oral

+∞

76.2

N94.5

ICD-10 Finland

Secondary dysmenorrhoea

6.5

75.9

205

324

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

75.5

2173

14949

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

74.1

JN4BD

NOMESCO Finland

Extensive body CT

3.5

73.8

368

1097

L02BG03

ATC

anastrozole; oral

153.9

72.1

N80.89

ICD-10 Finland

Endometriosis with other specified or multiple localization

242.8

70.4

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

69.9

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

2.9

69.5

455

1647

X76

ICPC

Malignant neoplasm breast female

182.1

69.2

LBE01

NOMESCO Finland

Laparoscopic salpingectomy

4.7

68.7

246

543

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

341.0

67.7

L02AE03

ATC

goserelin; implant

15.5

66.5

111

XX3DW

NOMESCO Finland

Time consuming IT work

3.2

66.1

378

1247

1410

FHL

Laparoscopy

3.5

65.9

331

991

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

23.5

65.8

62539

ICD-8 Finland

Other diseases of uterus, Endometriosis NUD

+∞

65.7

LCB10

NOMESCO Finland

Myomectomy

13.8

65.6

115

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

5.1

65.2

215

434

WF049

NOMESCO Finland

Radiotherapy of metastasis

325.5

64.6

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

2.1

63.8

843

4384

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

2.7

63.8

484

1916

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

63.6

61610

ICD-8 Finland

Diseases of parametrium and pelvic peritoneum (female), Pelvic peritoneal adhesions, female

5.8

63.4

188

335

LCB11

NOMESCO Finland

Laparoscopic myomectomy

16.4

63.1

103

ZX080

NOMESCO Finland

Image guided radiotherapy

166.8

63.1

N80.2

ICD-10 Finland

Endometriosis of fallopian tube

+∞

62.6

ZX090

NOMESCO Finland

Other technic of radiotherapy

98.3

61.9

N80.81

ICD-10 Finland

Endometriosis in sacrouteral ligament

614.4

61.9

H01CA02

ATC

nafarelin; nasal

4.3

60.9

240

582

8302

FHL

Tumor removal (e.g., enucleation) or polyp removal

8.3

60.7

138

169

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

60.5

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

60.5

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.3

59.9

632

2971

128

Kela drug reimbursment

Cancers of female genital organs

583.8

58.8

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

58.7

2231

16242

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

57.4

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

57.4

WX402

NOMESCO Finland

General anaesthesia

2.0

57.1

788

4161

G03FA01

ATC

norethisterone and estrogen; systemic (progestogens and estrogens, fixed comb.)

0.5

57.0

481

9087

L03AA02

ATC

filgrastim; parenteral

30.8

56.8

8351

FHL

Removal of pelvic floor brackets

9.5

56.8

119

127

L02AE02

ATC

leuprorelin; implant, parenteral

9.4

56.8

120

130

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.7

55.6

1540

10267

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

55.3

LCD11

NOMESCO Finland

Laparoscopically assisted vaginal hysterectomy

4.7

55.1

195

425

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

33.1

54.8

LBE20

NOMESCO Finland

Laparoscopic bilateral salpingectomy

6.4

54.4

148

237

N99.4

ICD-10 Finland

Postprocedural pelvic peritoneal adhesions

6.7

54.0

142

217

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

143.8

53.9

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

56.0

51.6

G03GA01

ATC

chorionic gonadotrophin; parenteral

3.3

51.6

275

861

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

51.1

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

8.1

51.1

118

149

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

178.2

51.0

A04AA01

ATC

ondansetron; systemic, rectal

3.6

50.5

243

703

WX302

NOMESCO Finland

Thoracal epidural anesthesy

4.1

49.0

199

497

62800

ICD-8 Finland

Sterility, female, Sterilitas primaria

4.8

48.9

169

360

WF002

NOMESCO Finland

Radical radiotherapy

19.2

48.3

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

471.5

47.4

G03DA04

ATC

progesterone; systemic, rectal, vaginal

2.7

46.4

345

1344

G03GA06

ATC

follitropin beta; parenteral

3.9

46.2

196

509

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

45.9

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

45.9

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

3.0

45.8

285

992

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

54.5

45.5

G03GA02

ATC

human menopausal gonadotrophin; parenteral

3.8

45.3

203

553

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

2.6

45.1

339

1327

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

2.0

44.4

668

3621

JN4AD

NOMESCO Finland

Body CT examination

3.3

44.0

230

710

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

7.2

43.6

108

152

A02BC02

ATC

pantoprazole; systemic

1.5

43.3

3738

31830

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

63.0

43.2

N80

ICD-10 Finland

Endometriosis

47.6

42.9

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

115.9

42.8

HAB99

NOMESCO Finland

Other partial excision of mammary gland

5.7

41.9

123

218

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

41.7

N02BE01

ATC

paracetamol; systemic, rectal

1.6

41.2

5047

46161

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

410.3

41.2

G03XB02

ATC

ulipristal; oral (progesterone receptor modulators)

12.5

40.8

ZXE00

NOMESCO Finland

One hour or less

1.5

40.7

2147

16446

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

40.7

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

40.7

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

7.2

40.6

100

140

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

11.1

40.2

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

31.4

40.1

N02AX02

ATC

tramadol; systemic, rectal

1.5

39.7

2243

17403

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

39.6

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

39.6

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.5

39.5

473

8149

NK6AN

NOMESCO Finland

Total body bone isotope imaging

14.4

39.4

8113

FHL

Fractional scraping

1.9

39.3

646

3608

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

201.3

38.8

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

379.8

38.1

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

84.6

37.8

M01AE02

ATC

naproxen; oral, rectal

1.4

37.7

3270

27464

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

37.5

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

37.5

A02BC05

ATC

esomeprazole; systemic

1.4

37.4

2414

19159

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

37.1

432

2104

SPAT1153

SPAT

Removal of sutures

1.5

36.2

1703

12653

LCF01

NOMESCO Finland

Laparoscopic excision of lesion of parametrium

68.7

36.0

B01AB05

ATC

enoxaparin; parenteral

1.5

35.9

1563

11417

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

3.2

35.5

192

608

1CD02

NOMESCO Finland

+∞

35.4

TLC00

NOMESCO Finland

Insertion of intrauterine device

2.1

35.3

410

1995

XLA10

NOMESCO Finland

2.1

35.3

448

2266

LAA10

NOMESCO Finland

Percutaneous or transvaginal puncture and recovery of oocyte

4.5

35.3

128

288

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

35.3

602

3403

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

13.1

34.5

TQW20

NOMESCO Finland

Tatoe

34.1

34.0

6500B

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

0.6

33.6

576

9096

LCA06

NOMESCO Finland

Biopsy of endometrium

1.6

33.4

914

5956

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

33.4

8343

FHL

Combined endometriosis surgery

+∞

33.4

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

33.4

N81.2

ICD-10 Finland

Incomplete uterovaginal prolapse

0.3

33.3

102

2833

LCC10

NOMESCO Finland

Supravaginal hysterectomy

6.9

32.3

121

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.4

31.9

284

1220

G03FB05

ATC

norethisterone and estrogen; systemic (progestogens and estrogens, sequential prep.)

0.6

31.6

435

7268

LEF13

NOMESCO Finland

Colpoperineoplasty and vaginal hysterectomy

0.2

31.6

1594

D39.10

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary without histology

3.0

31.6

191

655

J02AC01

ATC

fluconazole; systemic

1.4

31.3

2724

22562

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

31.3

J01DB01

ATC

cefalexin; oral

1.4

31.3

4518

40908

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

6.1

31.2

142

G03GA05

ATC

follitropin alfa; parenteral

3.5

31.1

150

437

Z51.5

ICD-10 Finland

Palliative care

3.9

30.7

129

334

N94.6

ICD-10 Finland

Dysmenorrhoea, unspecified

5.0

30.7

101

206

6289A

ICD-9 Finland

Infertility, female, Of unspecified origin[STERILITAS ET INFERTILITAS MULIERIS NUD PRIM]

5.6

30.6

165

355

Kela drug reimbursment

Dienogest

+∞

30.2

LAC00

NOMESCO Finland

Excision of ovarian cyst

13.8

30.2

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

155.7

29.7

LAD00

NOMESCO Finland

Partial excision of ovary

20.1

29.5

G03FA12

ATC

medroxyprogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)

0.4

29.5

139

3247

UJF32

NOMESCO Finland

Coloscopy

1.5

28.8

1360

10022

LCG31

NOMESCO Finland

Laparoscopic resection or transcision of sacrouterine ligaments

150.7

28.7

LCB14

NOMESCO Finland

Laparoscopic myolysis

4.0

28.6

116

292

LCD97

NOMESCO Finland

Other laparoscopic hysterectomy

9.7

28.5

S18

ICPC

Laceration/cut

1.4

28.4

2091

16737

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

28.1

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

+∞

28.1

P01AB01

ATC

metronidazole; oral, rectal

1.4

28.0

2392

19619

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

28.0

1522

11522

WZC30

NOMESCO Finland

Teaching

1.8

27.8

484

2749

L02AE01

ATC

buserelin; implant, nasal, parenteral

4.1

27.7

111

276

XX1XN

NOMESCO Finland

Other isotope examination

145.7

27.6

LAC20

NOMESCO Finland

Destruction of lesion of ovary

25.5

27.4

ZX120

NOMESCO Finland

Intravenous

2.0

27.4

352

1786

6421

FHL

Appendicectomy

2.1

27.3

334

1661

G03DB08

ATC

dienogest; oral

+∞

27.1

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

27.1

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

38.0

27.0

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.3

26.8

258

1151

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

272.2

26.7

G03FB06

ATC

medroxyprogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)

0.6

26.7

361

6074

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

8.6

26.6

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.6

26.5

770

5071

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.4

26.3

2051

16520

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

2.6

26.2

200

791

N83.1

ICD-10 Finland

Corpus luteum cyst

4.0

26.1

107

272

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

26.1

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

+∞

26.1

L01CA04

ATC

vinorelbine; systemic

+∞

26.1

L02AB02

ATC

medroxyprogesterone; systemic (progestogens)

9.9

25.9

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

261.7

25.7

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.0

25.7

324

1633

Z51.0

ICD-10 Finland

Radiotherapy session

93.8

25.6

G03FA14

ATC

dydrogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)

0.5

25.6

158

3360

61520

ICD-8 Finland

Other diseases of ovary and Fallopian tube, Cysta (cystis) follicularis ovarii (retentio)

3.1

25.3

140

453

B01AB10

ATC

tinzaparin; parenteral

2.2

25.2

267

1247

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

13.0

25.1

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

25.0

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

25.0

1501

Kela drug reimbursment

Palbociclib

+∞

25.0

N70.1

ICD-10 Finland

Chronic salpingitis and oophoritis

3.6

25.0

115

324

A02BA02

ATC

ranitidine; systemic

1.5

24.9

1111

8057

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

251.2

24.7

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

251.2

24.7

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

24.4

325

1669

R2110

NOMESCO Finland

Giving the first information

1.8

24.2

428

2438

6200A

ICD-9 Finland

Noninflammatory disorders of ovary, Fallopian tube and broad ligament, Follicular cyst of ovary

4.5

24.2

196

N80.6

ICD-10 Finland

Endometriosis in cutaneous scar

+∞

24.0

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

24.0

G03AC03

ATC

levonorgestrel; systemic

0.6

24.0

386

6230

ZX070

NOMESCO Finland

Intensity modified radiotherapy

37.7

23.9

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

240.9

23.7

JN4CD

NOMESCO Finland

Very extensive body CT

3.6

23.6

110

313

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

23.4

495

2983

6202X

ICD-9 Finland

Noninflammatory disorders of ovary, Fallopian tube and broad ligament, Other and unspecified ovarian cyst

2.9

23.3

145

508

WF004

NOMESCO Finland

Palliative radiotherapy

54.2

23.0

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

22.9

M01AG02

ATC

tolfenamic acid; oral, rectal

1.5

22.9

1006

7263

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

120.5

22.6

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.9

22.4

322

1708

UKC02

NOMESCO Finland

Cystoscopy

1.6

22.2

556

3515

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

35.1

22.0

6262A

ICD-9 Finland

Disorders of menstruation and other abnormal bleeding from female genital tract, Excessive or frequent menstruation[HYPERMENORRHOEA]

2.2

22.0

235

1103

394

Kela drug reimbursment

Palbociclib

+∞

21.9

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

21.9

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

21.9

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

62.7

21.8

C90.0

ICD-10 Finland

Multiple myeloma

80.4

21.7

HAD30

NOMESCO Finland

Reduction mammoplasty with transposition of areola

2.3

21.6

199

871

LBE00

NOMESCO Finland

Salpingectomy

4.8

21.6

155

N94.4

ICD-10 Finland

Primary dysmenorrhoea

4.6

21.4

161

Z3231

NOMESCO Finland

Registered nurse

1.4

21.1

1255

9580

6175A

ICD-9 Finland

Endometriosis of intestine

+∞

20.8

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

+∞

20.8

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

+∞

20.8

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

+∞

20.8

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

21.5

20.8

G03GB02

ATC

clomifene; oral

2.4

20.7

172

715

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

0.8

20.5

1570

19202

62660

ICD-8 Finland

Disorders of menstruation, Intermenstrual bleeding

2.0

20.5

252

1258

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

41.8

20.4

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

20.3

386

2249

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

20.3

1981

16341

TQW99

NOMESCO Finland

Other minor procedure on skin

2.3

20.2

194

867

JAL30

NOMESCO Finland

Omentectomy

6.5

20.0

LCD10

NOMESCO Finland

Vaginal hysterectomy

1.9

19.9

304

1649

N83.0

ICD-10 Finland

Follicular cyst of ovary

3.0

19.9

114

379

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

19.8

R4110

NOMESCO Finland

Physiotherapy

1.4

19.8

1229

9431

WX110

NOMESCO Finland

Local anesthesy

1.3

19.7

3543

31708

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

19.6

2046

17011

N02AA05

ATC

oxycodone; systemic

1.6

19.6

516

3304

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

105.4

19.6

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

105.4

19.6

Z35.0

ICD-10 Finland

Supervision of pregnancy with history of infertility

2.8

19.4

124

445

62400

ICD-8 Finland

Malposition of uterus, Retroversion and retroflexion

4.1

19.4

188

ZZR00

NOMESCO Finland

Flap of skin

6.7

19.3

N97.1

ICD-10 Finland

Female infertility of tubal origin

4.5

19.2

152

R01AD08

ATC

fluticasone; nasal

1.3

19.1

1549

12401

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

3.6

19.0

236

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

55.2

18.9

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.2

18.9

102

327

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.8

18.8

339

1944

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

18.8

L01XE33

ATC

[U] palbociclib; oral

+∞

18.8

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

18.8

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

18.8

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

18.8

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

18.8

192

Kela drug reimbursment

Fulvestrant

+∞

18.8

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

7.7

18.7

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

70.1

18.7

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

23.7

18.6

ZZR10

NOMESCO Finland

Flap of skin and muscle

18.7

18.6

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

8.9

18.6

ZSH00

NOMESCO Finland

Procedure related to previous procedure classified in chapter H

100.3

18.6

M01AH05

ATC

etoricoxib; oral

1.3

18.5

3321

29590

LAD01

NOMESCO Finland

Laparoscopic partial excision of ovary

8.4

18.4

62550

ICD-8 Finland

3.9

18.3

193

LA2AE

NOMESCO Finland

Ultrasound examination of ovarian cyst

3.5

18.3

244

LC2HE

NOMESCO Finland

Hystero-salpingography with ultrasound

1.9

18.2

280

1522

N06AX16

ATC

venlafaxine; oral

1.5

18.1

679

4723

6288A

ICD-9 Finland

Infertility, female, Of other specified origin[STERILITAS ET INFERTILITAS MULIERIS ALIA PRIM]

8.9

18.1

H02AB06

ATC

prednisolone; systemic

1.3

18.0

2469

21227

JAL97

NOMESCO Finland

Other laparoscopic excision of lesion of peritoneum

13.0

17.9

6172A

ICD-9 Finland

Endometriosis of Fallopian tube

+∞

17.7

L02BA03

ATC

fulvestrant; parenteral

+∞

17.7

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

17.7

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

+∞

17.7

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

17.7

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

+∞

17.7

N06AA09

ATC

amitriptyline; systemic

1.5

17.7

614

4201

1411

FHL

Laparoscopy and cyst puncture

5.3

17.6

100

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.5

17.5

133

529

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

180.5

17.5

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

180.5

17.5

8342

FHL

Cleavage and resection of sacrouterines

180.5

17.5

PJW99

NOMESCO Finland

Other operation on lymphatic system

180.5

17.5

N03AX16

ATC

pregabalin; oral

1.3

17.4

1250

9797

Z2221

NOMESCO Finland

Medical doctor

1.3

17.4

1391

11086

HAE99

NOMESCO Finland

Other reconstruction of breast

12.0

17.3

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

17.2

2588

22460

K66.0

ICD-10 Finland

Peritoneal adhesions

4.9

17.1

116

N63

ICD-10 Finland

Unspecified lump in breast

1.8

16.9

313

1810

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

16.8

1476

11915

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

16.8

5034

47706

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

21.9

16.8

WW500

NOMESCO Finland

Blood transfusion

2.8

16.8

107

383

LAE11

NOMESCO Finland

Unilateral laparoscopic oophorectomy

4.2

16.7

151

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

16.7

8500/3-C50.3

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast

+∞

16.7

FM1FN

NOMESCO Finland

Heart function isotope examination

+∞

16.7

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

16.7

HAC25

NOMESCO Finland

Radical mastectomy

+∞

16.7

8202

FHL

Oophorectomy

5.2

16.6

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

170.4

16.5

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

170.4

16.5

A79

ICPC

Malignancy NOS

27.6

16.5

D70.82

ICD-10 Finland

Drug-induced neutropenia

6.8

16.4

ULC02

NOMESCO Finland

Hysteroscopy

1.7

16.3

365

2235

G03GA04

ATC

urofollitropin; parenteral

3.7

16.3

194

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

16.2

375

2314

62620

ICD-8 Finland

Disorders of menstruation, Excessive

2.3

16.0

147

646

G03FB08

ATC

dydrogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)

0.5

16.0

179

3175

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

0.6

16.0

377

5618

Z3226

NOMESCO Finland

Physiotherapist

1.4

15.9

871

6515

J01MA12

ATC

levofloxacin; systemic

1.4

15.8

746

5426

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.8

15.8

353

C56.73

ICD-10 Finland

Endomeroid epithelial carcinoma of the ovary

+∞

15.6

C50.12

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,lobular tumor

+∞

15.6

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

15.6

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

15.6

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

+∞

15.6

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

15.6

N80.80

ICD-10 Finland

Bladder endometriosis

+∞

15.6

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

15.6

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

15.6

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

15.6

JGB04

NOMESCO Finland

Laparoscopic partial proctectomy with partial excision of mesorectum

85.3

15.6

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.8

15.5

346

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

9.4

15.4

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

5.2

15.4

6289B

ICD-9 Finland

Infertility, female, Of unspecified origin[STERILITAS ET INFERTILITAS MULIERIS NUD SEC]

4.6

15.4

117

H01CC01

ATC

ganirelix; parenteral

2.8

15.3

358

A03CA02

ATC

clidinium and psycholeptics; oral

1.7

15.2

344

2114

62699

ICD-8 Finland

Disorders of menstruation, Other

1.9

15.2

218

1158

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

23.4

15.1

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

15.0

857

6452

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

10.8

14.9

1350

FHL

Hysteroscopy

2.9

14.7

314

LCA30

NOMESCO Finland

Transfer of oocyte or embryo to uterus in assisted fertilisation

5.4

14.6

L01EF01

ATC

palbociclib; oral

+∞

14.6

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

+∞

14.6

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

+∞

14.6

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

14.6

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

14.6

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

14.6

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

14.6

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

14.6

1849

15618

8349

FHL

Other measure in this category

80.3

14.6

M03BX02

ATC

tizanidine; oral

1.2

14.5

3459

31413

LCA10

NOMESCO Finland

Curettage of body of uterus

2.0

14.5

183

928

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

150.3

14.5

TLW12

NOMESCO Finland

Insertion of frozen embryo

4.1

14.5

134

J01AA02

ATC

doxycycline; systemic

1.3

14.4

4497

42141

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

14.4

2563

22519

J02AC02

ATC

itraconazole; systemic

1.3

14.3

1016

7917

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

0.6

14.3

200

3352

R01AD09

ATC

mometasone; nasal

1.2

14.3

2458

21504

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

3.3

14.3

222

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.7

14.2

309

1877

J01FA10

ATC

azithromycin; systemic

1.2

14.1

3179

28649

HA1SA

NOMESCO Finland

Expansion mammography

14.4

14.0

A02BC01

ATC

omeprazole; systemic

1.3

14.0

1436

11792

TQB05

NOMESCO Finland

Puncture of skin of trunk

7.5

13.9

M79.7

ICD-10 Finland

Fibromyalgia

1.8

13.8

220

1211

ZX112

NOMESCO Finland

Subcutaneous

3.9

13.8

145

ZZF00

NOMESCO Finland

Graft of adipose tissue

7.8

13.8

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

53.4

13.8

HA1BG

NOMESCO Finland

MRI examination of mammary gland with high intensity magnet

11.4

13.7

J01MA02

ATC

ciprofloxacin; systemic

1.3

13.5

1811

15360

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

13.5

8461/3-C56.9

ICD-O-3

High grade serous carcinoma of ovary

+∞

13.5

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

13.5

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

+∞

13.5

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

13.5

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

13.5

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

13.5

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

+∞

13.5

N06AB04

ATC

citalopram; systemic

1.3

13.5

1170

9382

TLW10

NOMESCO Finland

Transfer of fresh embryo

3.7

13.5

158

JAH00

NOMESCO Finland

Laparotomy

2.6

13.5

369

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

140.3

13.4

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

140.3

13.4

R50.9

ICD-10 Finland

Fever, unspecified

1.5

13.4

474

3252

KCD02

NOMESCO Finland

Transurethral resection of bladder

7.7

13.3

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

13.3

358

2304

N93.8

ICD-10 Finland

Other specified abnormal uterine and vaginal bleeding

2.3

13.3

116

500

WX002

NOMESCO Finland

Sedation and analgesia

1.3

13.3

980

7677

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

1.8

13.2

220

1234

G02BA03

ATC

plastic IUD with progestogen

0.7

13.1

336

4937

L82

ICD-10 Finland

Seborrhoeic keratosis

1.4

13.1

815

6211

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

40.1

13.1

HA4ST

NOMESCO Finland

Labeling mammary gland pathology with sterotactic guidance

15.0

13.1

C07AA05

ATC

propranolol; systemic

1.3

13.0

1025

8109

WX702

NOMESCO Finland

Supraglottic ventilation device

1.8

12.8

212

1186

QB2S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in chest

11.5

12.8

61521

ICD-8 Finland

Other diseases of ovary and Fallopian tube, Cysta (cystis) corporis lutei ovarii

3.2

12.7

204

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

6.0

12.7

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

12.6

1205

9784

D05.9

ICD-10 Finland

Carcinoma in situ of breast, unspecified

70.0

12.6

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.6

12.5

332

2128

C43.72

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type

+∞

12.5

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

12.5

8380/3-C56.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of ovary

+∞

12.5

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

12.5

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

12.5

C50.1

ICD-10 Finland

Malignant neoplasm: Central portion of breast

+∞

12.5

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

12.5

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

+∞

12.5

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

12.4

1137

9175

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

24.3

12.4

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

3.3

12.4

191

WX704

NOMESCO Finland

Intubation

1.7

12.4

286

1766

G44.2

ICD-10 Finland

Tension-type headache

1.4

12.4

732

5531

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

3.6

12.4

155

ZXD20

NOMESCO Finland

Day surgery

1.4

12.4

658

4887

LAE10

NOMESCO Finland

Unilateral oophorectomy

4.9

12.3

62630

ICD-8 Finland

Disorders of menstruation, Painful

2.8

12.2

293

JEA00

NOMESCO Finland

Appendectomy

1.7

12.2

249

1487

N39.3

ICD-10 Finland

Stress incontinence

1.4

12.2

545

3919

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

37.6

12.2

J01DA01

ATC

[U] cefalexin; systemic

1.2

12.2

3376

30861

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

12.0

118

539

M01AX05

ATC

glucosamine; oral

1.3

12.0

1264

10383

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.0

12.0

148

745

A02BC03

ATC

lansoprazole; oral

1.2

11.9

1581

13362

J01FA09

ATC

clarithromycin; systemic

1.2

11.8

1690

14396

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

6.4

11.8

HAD99

NOMESCO Finland

Other plastic operation on breast

7.9

11.8

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

11.8

971

7719

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

11.7

453

3165

O34.1

ICD-10 Finland

Maternal care for tumour of corpus uteri

4.8

11.7

C56

ICD-10 Finland

Malignant neoplasm of ovary

65.1

11.6

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.9

11.6

162

856

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

11.5

2325

20535

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.1

11.5

126

602

A03FA02

ATC

cisapride; oral, rectal

1.5

11.5

429

2973

W12

ICPC

Contraception intrauterine

0.5

11.5

112

2065

N06AX11

ATC

mirtazapine; oral

1.2

11.5

1640

13957

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

+∞

11.5

C50.52

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor

+∞

11.5

C50.39

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology

+∞

11.5

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

11.5

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

+∞

11.5

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

+∞

11.5

6179X

ICD-9 Finland

Endometriosis, site unspecified

+∞

11.5

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

11.5

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

+∞

11.5

M70.6

ICD-10 Finland

Trochanteric bursitis

1.3

11.4

838

6547

QBE30

NOMESCO Finland

Excision and repair of surgical scar in trunk

5.6

11.4

M01AB05

ATC

diclofenac; systemic, rectal

1.2

11.4

3633

33567

JFB30

NOMESCO Finland

Right hemicolectomy

4.9

11.4

D25

ICD-10 Finland

Leiomyoma of uterus

2.6

11.3

302

M01AH01

ATC

celecoxib; oral (coxibs)

1.3

11.3

1034

8333

XX1AD

NOMESCO Finland

Other CT-examination

35.1

11.3

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

11.2

1331

11083

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.3

11.2

839

6575

HAB00

NOMESCO Finland

Excision of lesion of mammary gland

2.0

11.2

133

659

C05AA08

ATC

fluocortolone; rectal, topical

1.3

11.1

713

5453

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

11.1

479

3419

S77

ICPC

Malignant neoplasm of skin

10.0

11.0

D01

ICPC

Abdominal pain/cramps general

1.4

11.0

505

3651

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

43.4

10.9

M05BA02

ATC

clodronic acid; systemic

43.4

10.9

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.7

10.9

241

1473

R06AE07

ATC

cetirizine; oral

1.2

10.8

2405

21412

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.6

10.8

271

1718

LBE10

NOMESCO Finland

Bilateral salpingectomy

10.6

10.7

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

28.0

10.7

6201A

ICD-9 Finland

Noninflammatory disorders of ovary, Fallopian tube and broad ligament, Corpus luteum cyst or haematoma

3.8

10.7

117

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

17.8

10.7

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.4

10.7

590

4405

N05CF01

ATC

zopiclone; oral

1.2

10.6

1639

14045

LCB97

NOMESCO Finland

Other laparoscopic excision of lesion of uterus

60.1

10.6

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

60.1

10.6

N92.4

ICD-10 Finland

Excessive bleeding in the premenopausal period

1.6

10.6

255

1599

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

10.6

112

529

ICD-9 Finland

4.1

10.6

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

4.0

10.5

104

JN2CM

NOMESCO Finland

Lower part of abdomen extensive MRI examination with Tesla magnet

11.2

10.5

M01AX17

ATC

nimesulide; oral

1.2

10.5

1364

11467

22099

ICD-8 Finland

Benign neoplasm of ovary, Other and unspecified

2.1

10.5

109

512

C43.60

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder without histology

110.2

10.4

197

Kela drug reimbursment

Sunitinib

+∞

10.4

C43.69

ICD-10 Finland

Malignant melanoma of the upper extremity including shoulder other or unspecified histology

+∞

10.4

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

10.4

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

10.4

C50.93

ICD-10 Finland

Malignant tumor in other specified localization in mammary gland other or unspecified histology

+∞

10.4

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

+∞

10.4

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

+∞

10.4

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

10.4

8500/3-C50.8

ICD-O-3

Infiltrating duct carcinoma, NOS, of overlapping lesion of breast

+∞

10.4

8441/3-C56.9

ICD-O-3

Serous carcinoma, NOS, of ovary

+∞

10.4

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

+∞

10.4

17402

ICD-8 Finland

Malignant neoplasm of breast, Glandulae

+∞

10.4

1742A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-inner quadrant

+∞

10.4

M79.6

ICD-10 Finland

Pain in limb

1.2

10.4

1964

17181

LA2JE

NOMESCO Finland

Follow-up of menstrual cycle with repeated measurement of ovarian cyst

5.4

10.4

6282A

ICD-9 Finland

Infertility, female, Of tubal origin[STERIL ET INFERT EX ORIG TUBAE UTERINAE PRIM]

4.7

10.4

21900

ICD-8 Finland

Other benign neoplasm of uterus, Papiloma, polyp

2.5

10.3

325

N06AX21

ATC

duloxetine; oral

1.4

10.3

564

4205

LAG01

NOMESCO Finland

Laparoscopic freeing of adhesions of ovary

12.0

10.3

XF402

NOMESCO Finland

ECG with work load test

1.4

10.3

511

3745

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

10.3

1795

15569

M01AG01

ATC

mefenamic acid; oral

1.9

10.1

150

808

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

10.1

2241

19897

2200A

ICD-9 Finland

Benign neoplasm of ovary[NEOPLASMA BENIGNUM OVARII]

2.3

10.1

380

L57.0

ICD-10 Finland

Actinic keratosis

1.5

10.1

354

2425

6280A

ICD-9 Finland

Infertility, female, Associated with anovulation[STERILITAS ET INFERTILITAS ANOVULATORIA PRIM]

6.9

10.1

J01CA08

ATC

pivmecillinam; oral

1.2

10.0

2918

26565

JFB46

NOMESCO Finland

Resection of sigmoid colon

3.1

10.0

178

HWD00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of mammary gland

5.8

9.9

N30.0

ICD-10 Finland

Acute cystitis

1.3

9.9

807

6393

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.5

9.9

285

ZXC96

NOMESCO Finland

Robot assisted procedure

3.5

9.9

131

J01MA01

ATC

ofloxacin; systemic

1.5

9.9

367

2544

M01AH02

ATC

rofecoxib; oral

1.3

9.9

732

5724

LAE20

NOMESCO Finland

Bilateral oophorectomy

4.2

9.8

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

26.0

9.8

M54.5

ICD-10 Finland

Low back pain

1.2

9.8

1710

14818

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.7

9.7

184

1076

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

4.2

9.7

D27.91

ICD-10 Finland

Benign epithelial tumor of the ovary (ovary)

2.3

9.7

397

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.0

9.7

113

560

PJA01

NOMESCO Finland

Laparoscopic sentinel node excision

55.1

9.6

S04

ICPC

Lump/swelling localized

1.4

9.6

410

2927

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

9.6

921

7458

6266A

ICD-9 Finland

Disorders of menstruation and other abnormal bleeding from female genital tract, Metrorrhagia

1.6

9.6

266

1728

Z31.5

ICD-10 Finland

Genetic counselling

1.8

9.5

161

912

C07AB07

ATC

bisoprolol; oral

1.2

9.5

2334

20884

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

3.1

9.5

168

SPAT1308

SPAT

Sexual health counselling

0.6

9.5

123

2100

HA1CM

NOMESCO Finland

Mammary gland extensive MRI examination with 3 Tesla magnet

15.0

9.5

JAL01

NOMESCO Finland

Laparoscopic biopsy of peritoneum

9.1

9.5

62801

ICD-8 Finland

Sterility, female, Sterilitas secundaria

2.8

9.5

218

N95.0

ICD-10 Finland

Postmenopausal bleeding

0.7

9.5

309

4349

R51.80

ICD-10 Finland

Headache

1.3

9.5

703

5497

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

2.2

9.5

400

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.8

9.4

165

942

A07AA02

ATC

nystatin; oral

1.5

9.4

317

2153

1XC03

NOMESCO Finland

100.2

9.4

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

100.2

9.4

ZX095

NOMESCO Finland

Combined chemoradiotherapy

100.2

9.4

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

100.2

9.4

K07.60

ICD-10 Finland

Snapping jaw

1.6

9.4

247

1583

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

17.5

9.4

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

+∞

9.4

8720/3-C44.6

ICD-O-3

Malignant melanoma, NOS, of skin of upper limb and shoulder

+∞

9.4

C18.10

ICD-10 Finland

Malignant tumor of the appendix without histology

+∞

9.4

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

9.4

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

9.4

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

+∞

9.4

159

Kela drug reimbursment

Pazopanib

+∞

9.4

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

9.4

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

+∞

9.4

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

9.4

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

9.4

C57.0

ICD-10 Finland

Malignant neoplasm: Fallopian tube

+∞

9.4

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.4

9.4

505

3754

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.5

9.3

288

1920

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

9.3

295

1975

JAL00

NOMESCO Finland

Biopsy of peritoneum

5.8

9.3

JN6AD

NOMESCO Finland

CT of torso and neck

5.5

9.3

N05BA04

ATC

oxazepam; oral

1.2

9.3

1246

10492

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

9.3

2084

18483

LBF00

NOMESCO Finland

Perfusion of Fallopian tube

4.2

9.2

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

3.4

9.2

128

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

9.2

298

2007

N97.4

ICD-10 Finland

Female infertility associated with male factors

2.5

9.1

268

M03BC51

ATC

orphenadrine, combinations; systemic

1.2

9.1

1490

12814

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.0

9.1

106

524

MA2HE

NOMESCO Finland

Detailed morfological ultrasound examination of fetus

0.7

9.1

219

3258

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

9.0

3019

27711

HWH99

NOMESCO Finland

Other reoperation in surgery of mammary gland

11.5

9.0

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

9.0

2028

17976

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

5.6

9.0

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

36.7

9.0

6288B

ICD-9 Finland

Infertility, female, Of other specified origin[STERILITAS ET INFERTILITAS MULIERIS ALIA SEC]

9.0

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.0

9.0

106

530

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.4

8.9

293

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

2.5

8.9

258

LEG10

NOMESCO Finland

Vaginal urethrocystopexy

1.7

8.9

190

1153

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.4

8.9

436

3191

6253A

ICD-9 Finland

Pain and other symptoms associated with female genital organs, Dysmenorrhoea

3.0

8.9

160

SPAT1190

SPAT

Insertion or removal of intrauterine contraceptive device

0.5

8.8

1197

N97.2

ICD-10 Finland

Female infertility of uterine origin

9.5

8.8

XF400

NOMESCO Finland

ECG with 12 standard connections

1.3

8.7

632

4922

1530

FHL

Urethrocystoscopy

2.5

8.7

263

R84

ICPC

Malignant neoplasm bronchus/lung

50.0

8.7

M03BC01

ATC

orphenadrine (citrate); systemic

1.2

8.7

1178

9929

6210A

ICD-9 Finland

Disorders of uterus, not elsewhere classified, Polyp of corpus uteri

2.5

8.6

251

G04BD12

ATC

mirabegron; oral

1.4

8.6

505

3810

KAC11

NOMESCO Finland

Total nephrectomy with capsule, transcutaneous

16.3

8.5

M02AA07

ATC

piroxicam; topical

1.2

8.5

2058

18339

R30.0

ICD-10 Finland

Dysuria

1.7

8.5

159

932

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.7

8.5

186

1139

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.7

8.5

160

937

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

20.0

8.5

JAL96

NOMESCO Finland

Other excision of lesion of peritoneum

20.0

8.5

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

1.6

8.4

232

1509

R31

ICD-10 Finland

Unspecified haematuria

1.5

8.4

241

1580

JN2BG

NOMESCO Finland

MRI examination of lower part of abdoment with high intensity magnet

5.6

8.4

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

90.2

8.4

PJD53

NOMESCO Finland

Block dissection of aortic lymph nodes

90.2

8.4

EJA10

NOMESCO Finland

Biopsy of tongue or floor of mouth

2.1

8.4

410

LDW96

NOMESCO Finland

Other operation on cervix uteri

4.7

8.4

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

3.1

8.4

144

LAA06

NOMESCO Finland

Transvaginal puncture of ovarian cyst

3.2

8.3

128

8310/3-C56.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of ovary

+∞

8.3

6176A

ICD-9 Finland

Endometriosis in scar of skin

+∞

8.3

8091/3-C44.9

ICD-O-3

Superficial basal cell carcinoma of skin, NOS

+∞

8.3

L01XE04

ATC

[U] sunitinib; oral

+∞

8.3

1749X

ICD-9 Finland

Malignant neoplasm of female breast, Breast (female), unspecified

+∞

8.3

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

8.3

19399

ICD-8 Finland

Malignant neoplasm of thyroid gland

+∞

8.3

L04AX04

ATC

lenalidomide; oral

+∞

8.3

HAF00

NOMESCO Finland

Excision of local recurrence of breast cancer

+∞

8.3

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

+∞

8.3

C50.32

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, lobular tumor

+∞

8.3

8522/3-C50.9

ICD-O-3

Infiltrating duct and lobular carcinoma of breast, NOS

+∞

8.3

3AA13

NOMESCO Finland

+∞

8.3

C92.1

ICD-10 Finland

Chronic myeloid leukaemia [CML], BCR/ABL-positive

+∞

8.3

C50.2

ICD-10 Finland

Malignant neoplasm: Upper-inner quadrant of breast

+∞

8.3

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

8.3

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.2

8.3

381

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.3

8.3

301

J05AB11

ATC

valaciclovir; oral

1.3

8.2

629

4936

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.3

8.2

689

5476

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

2.3

8.2

304

J01FA06

ATC

roxithromycin; oral

1.2

8.2

2174

19518

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.3

8.2

539

4140

N03AX12

ATC

gabapentin; oral

1.3

8.1

774

6253

R03AC02

ATC

salbutamol; inhalant

1.2

8.1

2811

25782

Z37.0

ICD-10 Finland

Single live birth

0.6

8.1

127

2066

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

33.4

8.1

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

8.1

1195

10152

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

3.4

8.0

105

D48.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Breast

2.1

8.0

408

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

22.0

8.0

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

22.0

8.0

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.4

8.0

326

2309

N64.9

ICD-10 Finland

Disorder of breast, unspecified

2.6

7.9

213

ZXA10

NOMESCO Finland

Bilateral

1.2

7.9

926

7665

LAE21

NOMESCO Finland

Bilateral laparoscopic oophorectomy

4.0

7.9

R52.9

ICD-10 Finland

Pain, unspecified

1.4

7.9

391

2868

8219

FHL

Other measure in this category

4.7

7.9

LAA31

NOMESCO Finland

Ovarioscopy

6.6

7.9

D24

ICD-10 Finland

Benign neoplasm of breast

1.9

7.9

104

545

F20.9

ICD-10 Finland

Schizophrenia, unspecified

0.2

7.8

406

T81.2

ICD-10 Finland

Accidental puncture and laceration during a procedure, not elsewhere classified

2.4

7.8

270

N05BA12

ATC

alprazolam; oral

1.3

7.8

514

3950

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.2

7.7

333

N84.0

ICD-10 Finland

Polyp of corpus uteri

1.3

7.7

475

3611

R53

ICD-10 Finland

Malaise and fatigue

1.2

7.7

960

7999

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.3

7.7

561

4370

Z31.2

ICD-10 Finland

In vitrofertilization

3.6

7.7

C44.50

ICD-10 Finland

Malignant tumor of the skin on the torso without histology

45.0

7.7

XF404

NOMESCO Finland

Ambulatory ECG

1.4

7.7

398

2944

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

7.4

7.7

Z54.0

ICD-10 Finland

Convalescence following surgery

2.1

7.6

361

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

0.2

7.6

379

A06AC51

ATC

ispaghula, combinations; systemic

1.5

7.6

250

1693

R01AD12

ATC

fluticasone furoate; nasal

1.2

7.6

1452

12633

ZXA00

NOMESCO Finland

Right side

1.2

7.6

1271

10923

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.4

7.6

314

2226

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.4

7.6

296

2078

N94.1

ICD-10 Finland

Dyspareunia

2.7

7.6

183

WX306

NOMESCO Finland

Lumbar epidural anesthesy

1.5

7.6

252

1710

LCF97

NOMESCO Finland

Other laparoscopic excision of lesion of parametrium

25.0

7.6

LCF96

NOMESCO Finland

Other excision of lesion of parametrium

25.0

7.6

HAE00

NOMESCO Finland

Reconstruction of breast using prosthesis

11.8

7.6

D22.7

ICD-10 Finland

Melanocytic naevi of lower limb, including hip

2.2

7.5

311

J01EA01

ATC

trimethoprim; systemic

1.2

7.5

1534

13431

D06

ICPC

Abdominal pain localized other

1.4

7.5

385

2838

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.4

7.5

296

2080

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

6.1

7.5

H03AA01

ATC

levothyroxine sodium; systemic

1.2

7.5

1469

12811

J05AB01

ATC

aciclovir; systemic

1.2

7.5

1059

8950

M01AB01

ATC

indometacin; systemic, rectal

1.5

7.5

251

1711

G01AF04

ATC

miconazole; vaginal

1.4

7.4

316

2255

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.3

7.4

620

4922

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.3

7.4

653

5222

PJA10

NOMESCO Finland

Exploration of lymph nodes

3.8

7.4

XKC03

NOMESCO Finland

Water cystometry

1.6

7.4

170

1055

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

80.2

7.4

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

80.2

7.4

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

80.2

7.4

R01AD11

ATC

triamcinolone; nasal

1.3

7.4

440

3327

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.0

7.4

449

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.2

7.4

858

7095

HAD40

NOMESCO Finland

Mastopexy

5.3

7.4

XKD00

NOMESCO Finland

Uroflowmetry

1.5

7.4

214

1413

MAX99

NOMESCO Finland

Assistance to normal delivery

0.6

7.4

1542

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.3

7.4

280

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.0

7.3

465

R07.4

ICD-10 Finland

Chest pain, unspecified

1.2

7.3

1320

11421

W78

ICPC

Pregnancy

0.6

7.3

110

1808

G04BD08

ATC

solifenacin; oral

1.4

7.3

336

2434

8522/3-C50.4

ICD-O-3

Infiltrating duct and lobular carcinoma of upper-outer quadrant of breast

+∞

7.3

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

7.3

8480/3-C50.9

ICD-O-3

Mucinous adenocarcinoma of breast, NOS

+∞

7.3

C34.17

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary carcinoid

+∞

7.3

C43.70

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip without histology

+∞

7.3

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

+∞

7.3

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

7.3

8520/3-C50.5

ICD-O-3

Lobular carcinoma, NOS, of lower-outer quadrant of breast

+∞

7.3

L01AX03

ATC

temozolomide; systemic

+∞

7.3

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

+∞

7.3

155

Kela drug reimbursment

Afatinib and gefitinib

+∞

7.3

L01XE11

ATC

[U] pazopanib; oral

+∞

7.3

158

Kela drug reimbursment

Everolimus

+∞

7.3

8520/3-C50.2

ICD-O-3

Lobular carcinoma, NOS, of upper-inner quadrant of breast

+∞

7.3

6174A

ICD-9 Finland

Endometriosis of rectovaginal septum and vagina

+∞

7.3

C57.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of female genital organs

+∞

7.3

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

+∞

7.3

9706

FHL

Ablation mammae, includes axillary exploration

+∞

7.3

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

+∞

7.3

C17.0

ICD-10 Finland

Malignant neoplasm: Duodenum

+∞

7.3

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

+∞

7.3

C43.73

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip nodular

+∞

7.3

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

7.3

1930A

ICD-9 Finland

Malignant neoplasm of thyroid gland[CARCINOMA PAPILLARE THYREOIDEAE]

+∞

7.3

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

+∞

7.3

C56.74

ICD-10 Finland

Mesonephroid epithelial carcinoma of the ovary

+∞

7.3

8500/2-C50.4

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of upper-outer quadrant of breast

+∞

7.3

SPAT1131

SPAT

Colonoscopy

1.7

7.3

149

899

G03FA17

ATC

drospirenone and estrogen; systemic

0.5

7.3

1045

ZXC50

NOMESCO Finland

Cryotherapy

1.9

7.2

487

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

15.7

7.2

62650

ICD-8 Finland

Disorders of menstruation, Irregular

1.9

7.2

489

S82

ICPC

Naevus/mole

1.3

7.2

548

4300

TLC02

NOMESCO Finland

Simple extraction of IUD

1.6

7.2

201

1312

HA6HA

NOMESCO Finland

Tomosynthesis assessment of mammary gland specimen

30.0

7.1

R35

ICD-10 Finland

Polyuria

1.5

7.1

199

1301

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

20.0

7.1

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.3

7.1

422

3192

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.3

7.1

464

3560

8203

FHL

Salpingectomy

3.0

7.1

128

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

12.0

7.1

JFW96

NOMESCO Finland

Other operation on intestine

10.0

7.0

5702

FHL

Local lymph node removal (eg armpit, groin)

10.0

7.0

G04BD04

ATC

oxybutynin; oral, transdermal

1.4

7.0

295

2104

61620

ICD-8 Finland

Diseases of parametrium and pelvic peritoneum (female), Pelvic congestion, female

4.3

7.0

SPAT1263

SPAT

Sampling

1.2

7.0

2123

19192

L01

ICPC

Neck symptom/complaint

1.3

7.0

690

5602

F51.0

ICD-10 Finland

Nonorganic insomnia

1.3

7.0

593

4720

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

4.0

6.9

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

3.2

6.9

102

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.9

6.9

139

J01FF01

ATC

clindamycin; systemic

1.2

6.9

1224

10566

LWE00

NOMESCO Finland

Reoperation for deep haemorrhage in gynaecological surgery

3.0

6.9

119

LEB10

NOMESCO Finland

Excision of lesion of vagina

3.0

6.9

119

WX400

NOMESCO Finland

Inhalation anesthesy

1.6

6.9

160

999

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

5.4

6.9

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

7.5

6.9

K59.09

ICD-10 Finland

Constipation, unspecified

1.5

6.9

245

1688

Z30.0

ICD-10 Finland

General counselling and advice on contraception

0.5

6.9

1108

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

2.2

6.8

313

TQW40

NOMESCO Finland

Remowal of suture of skin

1.4

6.8

291

2080

X19

ICPC

Breast lump/mass female

2.2

6.8

317

LAB01

NOMESCO Finland

Laparoscopic ovariotomy

10.9

6.8

HA1ST

NOMESCO Finland

Biopsy of mammary gland with sterotactic guidance

9.3

6.8

M79.1

ICD-10 Finland

Myalgia

1.3

6.8

632

5091

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.3

6.8

509

3985

LCF00

NOMESCO Finland

Excision of lesion of parametrium

40.1

6.8

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

40.1

6.8

153

Kela drug reimbursment

Lenalidomid

40.1

6.8

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

40.1

6.8

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

1.7

6.7

121

705

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.3

6.7

491

3831

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

4.7

6.7

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.2

6.7

1542

13625

M01AH03

ATC

valdecoxib; oral

1.4

6.7

307

2225

KCH01

NOMESCO Finland

Percutaneous endoscopic suture of bladder

22.5

6.7

G01AF05

ATC

econazole; vaginal

1.3

6.6

527

4158

B01AB04

ATC

dalteparin; parenteral

1.5

6.6

189

1244

H02AB07

ATC

prednisone; oral

1.3

6.6

687

5604

D39.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Uterus

3.1

6.6

106

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.3

6.6

445

3431

HA2AT

NOMESCO Finland

Cytology of mammary gland with ultrasound guidance

7.8

6.6

R01AD05

ATC

budesonide; nasal

1.3

6.6

379

2855

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.4

6.6

282

2016

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.5

6.6

206

1383

6561

FHL

Removal of fasteners and related measures

3.5

6.6

XKD03

NOMESCO Finland

Urethral pressure profilometry

1.6

6.5

141

868

QBA00

NOMESCO Finland

Puncture of skin of trunk

5.0

6.5

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.6

6.5

144

890

A06AD11

ATC

lactulose; oral

1.3

6.5

563

4499

A06AH03

ATC

naloxegol; oral

4.5

6.4

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.5

6.4

200

1340

Y0609

ICD-8 Finland

Examination of the urinary and genital organs, Genital organs

1.8

6.4

527

LWW96

NOMESCO Finland

Other reoperation in gynaecological surgery

3.3

6.4

M19.9

ICD-10 Finland

Arthrosis, unspecified

1.5

6.4

203

1366

M25.5

ICD-10 Finland

Pain in joint

1.2

6.4

1499

13249

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

69.9

6.4

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

69.9

6.4

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

69.9

6.4

ZXA05

NOMESCO Finland

Left side

1.2

6.4

1161

10033

TLW00

NOMESCO Finland

Insemination

2.4

6.4

202

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

2.2

6.4

269

R05

ICD-10 Finland

Cough

1.2

6.4

959

8141

JHB00

NOMESCO Finland

Hemorrhoidectomy

1.6

6.4

158

1005

LAG00

NOMESCO Finland

Freeing of adhesions of ovary

14.3

6.4

SPAT1211

SPAT

Application of soft bandage

1.3

6.3

376

2843

JFF10

NOMESCO Finland

Loop enterostomy

6.5

6.3

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.0

6.3

346

K30

ICD-10 Finland

Functional dyspepsia

1.3

6.3

534

4254

JAA10

NOMESCO Finland

Excision of lesion of abdominal wall

9.2

6.3

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

1.8

6.3

100

559

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

6.2

9691/3-C77.9

ICD-O-3

Follicular lymphoma, grade 2 of lymph node, NOS

+∞

6.2

8090/3-C44.0

ICD-O-3

Basal cell carcinoma, NOS, of skin of lip, NOS

+∞

6.2

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

6.2

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

+∞

6.2

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

+∞

6.2

C69.30

ICD-10 Finland

Malignant tumor of the chorioidea without histology

+∞

6.2

8340/3-C73.9

ICD-O-3

Papillary carcinoma, follicular variant of thyroid gland

+∞

6.2

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

6.2

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

6.2

8240/3-C18.2

ICD-O-3

Neuroendocrine tumor, NOS, of ascending colon

+∞

6.2

WB303

NOMESCO Finland

Simple adjuvant therapy of malignancy with biomodifiers

+∞

6.2

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

+∞

6.2

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

+∞

6.2

L01CB01

ATC

etoposide; systemic

+∞

6.2

4CJ01

NOMESCO Finland

+∞

6.2

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

6.2

LCG30

NOMESCO Finland

Resection or transcision of sacrouterine ligaments

+∞

6.2

5BX04

NOMESCO Finland

+∞

6.2

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

+∞

6.2

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

6.2

JN5AN

NOMESCO Finland

Total body isotope imaging

+∞

6.2

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

6.2

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

6.2

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

6.2

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

6.2

C54.19

ICD-10 Finland

Malignant tumor of endometrium, unspecified histology

+∞

6.2

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

+∞

6.2

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

+∞

6.2

WW200

SPAT

0.7

6.2

294

3901

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

26.7

6.2

SPAT1324

SPAT

Screening procedure

0.8

6.2

773

9152

BAA60

NOMESCO Finland

Total thyroidectomy

1.8

6.2

100

565

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

1.9

6.2

447

LCA13

NOMESCO Finland

Curettage of cervix and body of uterus

1.3

6.2

406

3122

U02

ICPC

Urinary frequency/urgency

1.2

6.2

741

6150

Z30.4

ICD-10 Finland

Surveillance of contraceptive drugs

0.4

6.1

697

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.3

6.1

622

5061

N05AB04

ATC

prochlorperazine; systemic, rectal

1.7

6.1

119

710

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.3

6.1

558

4484

E870A

ICD-9 Finland

Accidental cut, puncture, perforation or haemorrhage during medical care

2.4

6.1

194

KH1AD

NOMESCO Finland

CT of urinary organs

1.8

6.1

527

M54.2

ICD-10 Finland

Cervicalgia

1.4

6.1

327

2433

Y60

ICD-10 Finland

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

2.3

6.1

233

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

1.7

6.1

117

695

R00.2

ICD-10 Finland

Palpitations

1.3

6.1

353

2658

D17.1

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

1.6

6.1

139

867

A01AB04

ATC

amphotericin B; local oral

1.4

6.1

248

1759

N92.5

ICD-10 Finland

Other specified irregular menstruation

1.9

6.1

469

N62

ICD-10 Finland

Hypertrophy of breast

1.5

6.1

187

1250

D27.99

ICD-10 Finland

Benign tumor of the ovary (ovary), unspecified histology

2.6

6.1

160

6208X

ICD-9 Finland

Noninflammatory disorders of ovary, Fallopian tube and broad ligament, Other noninflammatory disorders of ovary, Fallopian tube and broad ligament

3.7

6.1

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

2.7

6.0

143

G03CB01

ATC

dienestrol; oral, vaginal

1.5

6.0

191

1289

DHB00

NOMESCO Finland

Excision of lesion of external nose

4.9

6.0

R01AD01

ATC

beclometasone; nasal

1.2

6.0

767

6404

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

6.0

1144

9927

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.2

6.0

768

6410

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(4035726)

653

1665

4.25

230.22

1.4

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

70.04

152.61

1.0

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

156

137

11.64

151.03

4.4

1.1

u/ml

81.9

23.0

1.03

148

124

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

806

3150

2.78

141.25

3.0

1.5

u/ml

43.2

27.1

2.40

779

2995

(40768804) Tissue Pathology biopsy report

3021

20644

1.87

126.78

2.3

1.7

—

(3002256) Pathology report gross observation

1009

4626

2.40

126.10

1.3

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

750

3002

2.69

124.73

3.3

1.5

ug/l

23.9

7.6

0.96

580

2241

(40768793) Breast Pathology biopsy report

268

571

4.85

117.33

1.3

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

436

1406

3.25

106.63

1.5

1.3

pmol/l

81.2

77.2

0.16

421

1374

(3044640) Blood type and Crossmatch panel - Blood

2139

14818

1.66

73.71

2.2

2.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

23.36

70.67

1.1

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3323

25866

1.58

69.37

5.6

3.5

umol/l

10.2

10.5

0.52

3119

23987

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2983

22796

1.57

66.37

3.7

3.5

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4826

41994

1.58

53.86

7.5

5.4

u/l

76.3

75.5

0.73

4446

38718

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1590

11304

1.54

44.53

2.2

2.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

231

888

2.66

40.78

1.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2373

18587

1.44

39.89

3.2

2.1

mmol/l

2.4

0.18

1988

15509

(40768795) Lymph node Pathology biopsy report

122

5.71

37.28

1.2

1.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

3484

29432

1.40

36.85

8.5

6.6

e9/l

4.0

4.1

2.22

3023

25190

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

7.86

36.56

7.3

1.6

—

(3031040) Bacteria [#/volume] in Urine by Automated count

4324

37947

1.42

36.28

5.2

4.7

e6/l

3541.1

2674.2

0.29

439

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3024

25006

1.39

36.01

5.3

4.6

mmol/l

1.2

1.90

2654

22044

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3301

27876

1.37

33.64

6.0

5.1

mmol/l

1.2

1.33

2719

23348

(3013707) Erythrocyte sedimentation rate by Westergren method

4855

43745

1.43

33.25

4.4

4.3

mm/h

12.1

12.6

1.80

4403

40448

(4281824)

125

384

3.30

33.00

1.1

—

(42870588) Differential panel, method unspecified - Blood

2230

17747

1.39

32.35

5.5

5.6

—

(3006504) Eosinophils/100 leukocytes in Blood

2969

24763

1.37

32.13

5.7

5.8

2.8

2.9

1.76

2713

22747

(3019069) Monocytes/100 leukocytes in Blood

2978

24871

1.36

31.86

6.0

6.1

8.2

8.3

0.93

2748

22985

(3032080) INR in Blood by Coagulation assay

2476

20083

1.38

31.84

7.4

8.0

inr

1.2

1.20

740

5695

(3002030) Lymphocytes/100 leukocytes in Blood

3031

25488

1.35

30.52

5.8

5.9

28.7

28.9

0.63

2780

23414

(3037467) Urinalysis macro (dipstick) panel - Urine

4395

39290

1.37

28.79

5.0

4.6

—

(3022096) Basophils/100 leukocytes in Blood

2863

24004

1.34

28.77

5.8

0.7

0.32

2620

22060

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

5665

53003

1.53

28.39

13.8

10.8

ml/min/173m2

78.8

78.3

1.15

4769

42303

(3018010) Neutrophils/100 leukocytes in Blood

2979

25220

1.33

27.61

5.6

5.7

56.9

56.7

0.47

2737

23269

(3024561) Albumin [Mass/volume] in Serum or Plasma

2718

22724

1.34

27.36

4.0

3.5

g/l

35.8

36.0

0.92

2503

20660

(3019225) pH of Specimen

839

5739

1.53

26.57

3.9

3.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

726

4898

1.54

24.38

3.2

3.1

—

(3013512) EKG study

2033

16494

1.34

24.31

4.0

3.8

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

6094

58341

1.71

23.89

16.0

13.8

mmol/l

139.7

139.8

1.30

5935

56706

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

287

3.24

23.79

1.3

1.1

ug/l

2.0

2.3

0.41

221

(3023103) Potassium [Moles/volume] in Serum or Plasma

6107

58516

1.71

23.63

16.2

13.9

mmol/l

3.9

6.80

5936

56763

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

232

1146

2.06

23.04

3.1

1.9

u/ml

88.9

198.0

0.42

194

914

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

5.89

23.03

1.1

—

(3033658) Prothrombin time (PT) actual/Normal

1575

12381

1.36

22.96

3.6

3.2

95.6

94.1

1.49

1533

11985

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

153

645

2.41

22.38

2.4

2.0

u/ml

569.9

76.5

0.58

142

580

(3021589) Normoblasts [#/volume] in Blood

2775

23757

1.29

21.76

9.9

8.2

e9/l

0.0

0.23

2260

19406

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2094

17268

1.31

21.75

2.4

2.2

u/l

56.9

58.2

0.35

1889

15642

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5855

55727

1.51

21.16

14.3

11.9

mg/l

20.2

20.1

0.06

4691

42682

(3012095) Magnesium [Moles/volume] in Serum or Plasma

990

7355

1.41

20.07

2.7

2.2

mmol/l

0.8

1.76

895

6682

(3022145) Colonoscopy Study observation

829

5985

1.44

19.69

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1000

7477

1.40

19.48

4.8

4.7

33.9

33.5

0.59

657

4924

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

639

4403

1.50

19.25

3.4

2.9

u/l

243.7

243.1

0.03

585

4077

(3013115) Eosinophils [#/volume] in Blood

3177

27964

1.27

18.88

5.8

5.7

e9/l

0.2

3.45

2756

24433

(3006315) Basophils [#/volume] in Blood

3077

26997

1.27

18.73

5.6

e9/l

0.0

1.62

2630

23180

(3023368) Bacteria identified in Blood by Culture

1455

11610

1.33

18.56

3.9

3.6

—

(40758558) Short blood count panel - Blood

1546

12472

1.31

18.18

6.0

4.9

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

3468

30929

1.26

18.09

4.1

3.8

mmol/l

6.5

6.6

1.88

3273

28575

(3001604) Monocytes [#/volume] in Blood

3056

26860

1.26

18.07

5.6

e9/l

0.6

1.40

2614

23087

(3019198) Lymphocytes [#/volume] in Blood

3129

27614

1.26

17.72

5.7

5.6

e9/l

1.9

0.30

2740

24169

(40761536) Microorganisms panel - Urine sediment

630

4405

1.48

17.60

4.8

4.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

562

3867

1.50

16.99

2.2

2.0

g/l

0.2

1.45

530

3522

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1037

13252

0.74

16.75

1.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5141

48330

1.30

16.20

4.9

4.5

pmol/l

14.9

14.8

0.57

4622

44099

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3871

35200

1.25

16.05

3.2

2.8

u/l

44.5

39.6

2.65

3527

32389

(3041096) Erythrocytes [Presence] in Urine by Automated

1765

14736

1.27

15.48

4.1

3.6

—

(3002582) Erythrocytes [#/volume] in Urine

1816

15226

1.27

15.35

3.2

3.0

e6/l

38.6

67.7

1.62

1356

11300

(40768797) Stomach Pathology biopsy report

1067

8366

1.33

15.01

1.2

—

(3018095) Leukocytes [#/volume] in Urine

2179

18703

1.25

14.94

3.7

3.5

e6/l

101.9

118.4

0.57

1482

12509

(36304419) Bacteria [Presence] in Urine

1660

13819

1.27

14.79

3.1

2.9

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2424

21075

1.24

14.73

3.5

ng/l

25.5

60.2

1.61

1567

13692

(3026782) Osmolality of Urine

1221

9784

1.31

14.66

2.6

2.7

mosm/kgh2o

501.3

505.3

0.26

1015

8161

(3042936) Bacteria identified in Isolate by Culture

824

6289

1.36

13.82

1.8

1.9

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

744

5606

1.37

13.53

2.5

2.1

umol/l

5.8

6.4

0.56

644

4693

(3003338) MCHC [Mass/volume]

4425

47067

0.81

12.89

18.5

15.9

g/l

330.3

330.5

0.65

4396

46776

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6156

59900

1.52

12.67

11.2

9.2

u/l

23.8

23.4

1.02

5878

57334

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2752

24540

1.21

12.34

3.0

2.8

ug/l

103.5

94.3

0.99

2498

22598

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

381

2591

1.50

12.19

3.7

3.2

mmol/l

2.2

0.05

295

1980

(3018418) pH of Serum or Plasma

1935

16687

1.23

12.09

4.0

3.1

7.4

0.21

380

2805

(3030467) Casts [#/volume] in Urine by Automated count

1669

14193

1.24

11.87

3.1

2.9

e6/l

0.3

0.4

0.78

1233

10444

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

841

6579

1.32

11.83

2.4

2.5

21.6

21.7

0.14

723

5480

(40761511) CBC panel - Blood by Automated count

6006

58249

1.41

11.74

13.8

11.5

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

4.24

11.71

1.8

1.1

ng/l

57.8

83.4

0.44

(3022948) Iron [Moles/volume] in Serum or Plasma

989

7920

1.29

11.69

2.3

2.4

umol/l

13.0

12.9

0.12

897

7205

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5719

55107

1.31

11.21

6.0

5.4

mu/l

2.2

2.0

0.26

5194

50646

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

288

2.45

11.01

5.6

1.2

u/ml

217.2

290.0

0.28

(3009343) pH of Capillary blood

387

2696

1.46

10.99

3.8

3.2

7.4

0.05

372

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

391

2733

1.46

10.91

3.8

3.2

kpa

5.2

0.36

365

2507

(40768441) Liver Pathology biopsy report

278

2.46

10.85

1.4

1.3

—

(3022313) Gas panel - Capillary blood

291

1917

1.54

10.83

3.6

3.2

—

(3000850) Epithelial cells [#/volume] in Urine

1281

10675

1.25

10.82

2.7

2.4

e6/l

7.7

7.6

0.10

1090

9189

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

109

545

2.02

10.69

1.3

nmol/l

0.6

0.4

0.89

408

(3037121) Protein [Mass/volume] in Urine

251

1611

1.58

10.49

2.2

2.5

g/l

0.3

0.02

421

(3004789) Transferrin [Mass/volume] in Serum or Plasma

892

7143

1.29

10.48

2.3

2.4

g/l

2.4

0.27

811

6515

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

262

1699

1.56

10.47

3.8

3.4

mmol/l

25.3

0.04

244

1537

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

180

1068

1.70

10.27

2.0

2.5

g/l

3.5

0.05

168

994

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1462

12462

1.22

9.88

1.6

1.7

mg/l

1.1

0.16

1076

9459

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

608

4687

1.33

9.43

2.2

2.1

u/l

44.1

36.2

0.41

515

3923

(3048689) Calprotectin [Mass/mass] in Stool

899

7301

1.27

9.38

2.1

ug/g

108.1

118.3

0.54

669

5554

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

142

810

1.77

9.35

1.5

1.6

—

(3026008) Bacteria identified in Urine by Culture

2250

20080

1.18

9.13

3.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1898

16694

1.19

9.10

3.2

2.6

u/l

31.9

30.9

0.42

1794

15688

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

533

4054

1.34

9.06

3.2

3.0

pmol/l

4.4

0.13

478

3527

(3021601) Nitrite [Presence] in Urine by Test strip

3114

28566

1.17

9.00

5.6

5.4

estimate

0.0

1.60

645

4824

(3021440) Promyelocytes/100 leukocytes in Blood

537

4093

1.34

9.00

4.2

3.9

0.1

0.39

137

749

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1577

13671

1.20

8.82

2.3

mg/l

3.1

2.9

0.98

1297

11685

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

953

7848

1.25

8.79

2.7

2.6

e6/l

4.5

4.9

0.40

485

3998

(3009261) Glucose [Presence] in Urine by Test strip

3137

28827

1.17

8.79

4.2

4.0

estimate

0.0

2.04

648

4850

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

129

730

1.78

8.75

2.0

mg/l

24.3

24.7

0.03

183

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

579

4486

1.32

8.66

3.7

2.8

mmol/l

1.2

0.01

491

3735

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2914

26641

1.17

8.66

2.3

nmol/l

81.0

80.0

1.18

2525

23580

(3035350) Ketones [Presence] in Urine by Test strip

3090

28398

1.17

8.55

4.1

4.0

estimate

0.0

0.69

645

4796

(3017181) Myelocytes/100 leukocytes in Blood

550

4241

1.32

8.51

4.2

3.9

1.1

0.8

0.85

144

805

(3023323) Follitropin [Units/volume] in Serum or Plasma

383

2792

1.39

8.51

1.3

iu/l

33.5

34.7

0.28

334

2461

(3007164) IgA [Mass/volume] in Serum or Plasma

1299

11100

1.21

8.40

1.4

1.3

g/l

2.2

2.3

1.07

700

6329

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1821

16083

1.18

8.15

2.7

2.9

ng/l

1134.6

1190.9

0.25

1498

13674

(3002179) Metamyelocytes/100 leukocytes in Blood

512

3933

1.33

8.14

4.0

3.7

0.7

0.6

0.13

111

608

(3035941) MCH [Entitic mass]

6315

62152

1.55

8.10

21.7

17.8

30.0

30.2

7.20

6208

61090

(3024731) MCV [Entitic volume]

6315

62156

1.55

8.05

21.7

17.8

90.8

91.1

5.46

6208

61098

(3010813) Leukocytes [#/volume] in Blood

6316

62170

1.55

8.02

21.9

17.9

e9/l

6.5

0.12

6135

60050

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

149

903

1.67

7.95

1.3

1.2

nmol/l

0.6

2.4

0.74

144

865

(3026361) Erythrocytes [#/volume] in Blood

6315

62164

1.54

7.95

21.8

17.9

e12/l

4.4

1.08

6132

60057

(40768443) Skin Pathology biopsy report

335

2422

1.40

7.83

1.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

6315

62174

1.54

7.82

21.9

18.0

g/l

131.7

132.8

9.95

6209

61121

(3007461) Platelets [#/volume] in Blood

6311

62127

1.53

7.81

21.8

17.9

e9/l

265.1

263.0

1.82

6156

60237

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

158

978

1.63

7.77

2.8

3.3

59.1

57.5

0.82

158

978

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1246

10694

1.20

7.62

2.7

2.2

mmol/l

2.5

0.64

1093

9181

(3045414) Leukocytes [Presence] in Urine

374

2777

1.37

7.46

2.0

1.9

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

188

2822

0.66

7.46

1.4

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

100

553

1.82

7.39

1.7

1.2

—

(3049717) Cytology report of Urine Cyto stain

180

1166

1.56

7.34

2.3

1.9

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

184

1198

1.55

7.34

1.8

2.3

178.1

180.0

0.10

173

1111

(3027945) Reticulocytes/100 erythrocytes in Blood

635

5093

1.27

7.30

2.6

2.2

1.8

0.17

540

4405

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

7.29

1.0

0.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

131

796

1.66

6.97

1.2

nmol/l

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

145

909

1.61

6.83

1.3

1.2

nmol/l

0.5

0.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

161

2.49

6.74

1.1

105.0

92.9

1.58

(3017143) Hepatitis C virus Ab [Presence] in Serum

577

4621

1.27

6.72

1.5

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

262

2.15

6.70

3.6

1.2

nmol/l

169.8

76.7

0.77

255

(3026493) Urate [Moles/volume] in Serum or Plasma

1536

13578

1.17

6.57

2.3

2.1

umol/l

5961.8

4770.5

0.46

1281

11477

(3004809) Band form neutrophils/100 leukocytes in Blood

102

589

1.74

6.57

2.9

1.3

1.1

0.46

454

(3017732) Neutrophils [#/volume] in Blood

494

3898

1.29

6.48

2.7

e9/l

3.9

4.0

0.27

360

2925

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

308

2271

1.37

6.46

1.7

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

415

3201

1.32

6.45

1.8

1.7

—

(3035637) Corticotropin [Mass/volume] in Plasma

504

1.80

6.44

1.5

1.4

—

(1761868) Lipid panel - Serum or Plasma

2081

18850

1.15

6.42

3.0

2.9

—

(3025159) Blasts/100 leukocytes in Blood

499

3954

1.28

6.34

4.2

3.9

0.1

0.2

0.11

121

671

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

175

1167

1.51

6.31

1.9

1.8

u/l

297.8

3848.5

5.19

434

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

430

3349

1.30

6.23

2.6

2.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

471

3713

1.29

6.23

2.6

2.5

g/l

10.2

10.5

0.84

411

3405

(3021879) Hepatitis B virus core Ab [Presence] in Serum

375

2866

1.33

6.23

1.5

1.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

168

2.39

6.18

1.1

96.7

91.5

0.64

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

110

663

1.67

6.09

1.4

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

272

1987

1.38

6.06

1.9

—

(3045424) Erythrocytes [Presence] in Urine

152

996

1.54

5.97

1.7

1.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

110

667

1.66

5.97

1.4

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1537

13678

1.16

5.95

1.3

u/ml

1.5

1.4

0.06

350

3722

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

461

3649

1.28

5.92

1.8

1.7

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

132

840

1.58

5.90

1.3

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

253

1835

1.39

5.89

1.8

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

109

663

1.65

5.85

1.4

1.3

—

(3033799) Differential panel - Peritoneal fluid

3.15

5.73

1.5

2.3

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

581

4752

1.24

5.66

3.2

ng/l

81.9

83.2

0.18

480

3986

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

109

673

1.63

5.54

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

413

1.80

5.42

3.6

3.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

845

7215

1.20

5.37

1.9

29.4

0.04

816

6960

(3024522) Salmonella sp identified in Specimen by Organism specific culture

109

679

1.62

5.36

1.4

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

111

695

1.61

5.35

1.4

1.3

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

4.34

5.29

1.5

1.2

11.3

11.2

—

(3011412) CD3 cells [#/volume] in Blood

295

1.94

5.28

2.1

e9/l

1.3

1.2

0.18

157

(3023520) Reticulocytes [#/volume] in Blood

472

3810

1.26

5.18

2.6

2.2

e9/l

69.3

71.9

0.83

340

2864

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

111

707

1.58

5.01

1.4

1.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

451

3637

1.26

5.00

1.6

1.5

—

(3045142) Bone marrow Pathology biopsy report

331

1.85

4.93

1.3

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

208

1509

1.39

4.90

2.8

3.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

615

5148

1.21

4.82

2.1

1.8

nmol/l

373.9

366.3

0.42

558

4651

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

894

7743

1.18

4.81

1.7

1.8

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

169

1188

1.43

4.77

1.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1264

11266

1.15

4.68

1.3

u/ml

11.6

13.3

0.35

430

4362

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1929

17682

1.13

4.66

2.0

2.1

u/l

135.8

170.7

2.47

1772

16402

(40760892) CBC W Ordered Manual Differential panel - Blood

1313

11741

1.15

4.64

4.5

4.1

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

709

6040

1.20

4.62

4.6

4.4

mmol/l

1.0

0.49

652

5506

(3014271) Vancomycin [Susceptibility]

267

1.92

4.61

3.0

3.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

689

5856

1.20

4.61

1.7

1.8

—

(3009542) Hematocrit [Volume Fraction] of Blood

5146

49964

1.14

4.54

15.6

13.3

39.0

38.9

0.28

3556

34529

(40761535) Cells panel - Urine sediment

395

4871

0.80

4.47

3.1

3.6

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.59

4.46

1.0

1.1

100.3

81.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5757

56383

1.18

4.43

5.0

4.7

mmol/l

5.8

5.9

0.56

5139

51368

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

356

2842

1.27

4.34

1.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

331

1.79

4.33

1.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

362

2899

1.26

4.30

1.8

1.6

g/l

1.4

1.3

0.43

317

2645

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

121

815

1.49

4.29

1.3

u/l

31.9

34.1

0.29

634

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

280

2171

1.30

4.29

7.7

7.4

mmol/l

24.5

24.7

0.57

258

2000

(3002385) Erythrocyte distribution width [Ratio]

4741

45855

1.12

4.24

17.6

14.3

13.7

1.16

4652

44756

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1779

16309

1.12

4.22

1.6

mmol/l

1.4

1.3

1.51

1436

13603

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

199

2.02

4.21

1.4

1.5

u/l

12.8

13.3

0.17

191

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3509

33390

1.11

4.21

2.8

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

2.51

4.20

1.0

1.1

74.8

79.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

147

2.18

4.13

1.5

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

261

2017

1.31

4.12

1.8

1.7

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

215

1.96

4.09

1.8

2.4

e6/l

629.5

1238.8

0.80

112

(3009214) Lutropin [Units/volume] in Serum or Plasma

646

1.54

4.09

1.2

u/l

21.7

17.1

1.46

519

(3020630) Protein [Mass/volume] in Serum or Plasma

486

4046

1.22

4.06

2.6

1.6

g/l

66.1

66.9

1.47

433

3580

(4034850)

150

2082

0.71

4.05

9.3

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

2.86

4.05

4.9

1.4

u/l

59.3

41.7

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.52

4.04

1.2

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

142

2.19

4.04

1.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

142

2.19

4.04

1.4

—

(3019150) Specific gravity of Urine by Refractometry

1158

12899

0.88

4.03

4.6

kg/l

1.0

0.22

242

1953

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2655

24940

1.11

4.01

2.1

2.0

pmol/l

104.1

99.5

3.71

1172

11501

(40767503) Oxygen content in Capillary blood by calculation

136

953

1.44

3.97

2.8

2.5

15.6

16.2

0.95

486

(3021960) Folate [Moles/volume] in Serum or Plasma

1507

13727

1.13

3.95

1.6

1.5

nmol/l

21.7

21.8

0.18

1209

11508

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

225

1.92

3.95

1.8

2.2

e6/l

557.2

608.0

0.11

192

(3036489) Thrombin time

227

1732

1.32

3.94

1.5

1.8

20.8

21.3

1.11

197

1473

(3044889) 12 lead EKG panel

4120

39609

1.11

3.91

3.8

3.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

171

1252

1.38

3.89

1.8

1.7

mu/l

312.9

325.8

0.33

152

1114

(3040151) Glucose [Moles/volume] in Capillary blood

511

1.59

3.89

3.3

5.4

mmol/l

7.2

7.5

0.31

417

(3003694) ABO and Rh group [Type] in Blood

1359

12314

1.13

3.87

1.4

1.3

—

(4146454)

607

1.54

3.86

2.6

2.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

625

1.53

3.81

1.3

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

143

1020

1.41

3.81

3.1

2.7

mg/l

1.6

0.22

129

920

(3015183) Erythrocyte sedimentation rate

221

1.91

3.80

1.1

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

544

4611

1.20

3.78

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

224

1718

1.31

3.76

1.5

1.4

ug/g

286.3

294.8

0.29

128

981

(3022621) pH of Urine by Test strip

478

4010

1.21

3.71

3.0

3.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

163

1197

1.37

3.67

2.6

3.3

u/ml

0.3

0.4

1.79

718

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1048

9374

1.14

3.64

1.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

429

3569

1.22

3.64

2.3

1.5

—

(3021901) Oxygen saturation in Capillary blood

111

767

1.45

3.54

3.5

2.8

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

995

8889

1.14

3.52

2.6

2.5

e6/l

1.4

0.00

530

5008

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

199

1.91

3.52

1.4

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

199

1.91

3.52

1.4

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

199

1.91

3.52

1.4

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

148

1082

1.38

3.45

1.3

1.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.71

3.35

1.3

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5466

53523

1.13

3.35

5.9

5.8

mmol/mol

39.3

39.5

0.86

4949

49337

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

162

1209

1.35

3.33

1.3

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

196

1.89

3.33

2.0

1.9

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

168

1262

1.34

3.31

1.8

2.0

94.9

95.2

0.06

154

1138

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

211

1.85

3.29

2.0

1.8

14.8

0.01

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

300

1.71

3.27

1.3

1.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

665

1.47

3.25

4.0

4.8

iu/ml

293.1

1008.4

0.85

(3017354) Segmented neutrophils/100 leukocytes in Blood

409

1.60

3.22

3.0

2.8

51.0

59.3

1.77

272

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

279

1.73

3.21

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

124

892

1.40

3.21

1.3

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

310

1.68

3.18

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

200

1.85

3.15

1.4

1.3

—

(3028626) Oxygen [Partial pressure] in Capillary blood

125

904

1.39

3.14

3.4

2.7

kpa

8.3

8.2

0.37

118

838

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1291

11800

1.12

3.13

1.3

iu/ml

29.8

36.7

0.69

377

3862

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

283

1.70

3.07

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

231

1.78

3.07

2.2

1.9

37.0

46.3

—

(3037522) Nuclear Ab [Titer] in Serum

959

8626

1.13

3.05

1.4

titre

532.1

614.0

0.82

215

2038

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.58

3.04

1.1

1.9

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1244

11368

1.12

3.03

1.8

1.7

nmol/l

1156.3

1199.8

0.82

861

8513

(3023487) Leukocytes [#/volume] in Peritoneal fluid

100

2.20

2.98

1.8

2.4

e6/l

5602.4

633.7

0.46

(46235355) HIV 1 and 2 tests - Meaningful Use set

712

6297

1.15

2.94

1.7

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

442

3768

1.19

2.93

5.8

5.6

mmol/l

1.3

0.01

430

3638

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

647

1.44

2.93

1.4

1.3

u/ml

158.3

117.1

0.43

149

(36660697) Celiac disease serology panel - Serum

568

4945

1.16

2.91

1.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

409

3466

1.19

2.91

6.5

6.2

mmol/l

9.1

9.6

1.01

384

3278

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

240

0.37

2.90

10.0

10.3

nmol/l

1223.4

871.8

—

230

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

258

1.71

2.89

1.3

1.7

nmol/l

1.9

4.8

1.95

210

(3012441) Differential panel - Pleural fluid

266

1.70

2.87

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

149

1128

1.33

2.84

2.6

2.1

g/l

125.8

127.8

0.39

807

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

199

1567

1.28

2.83

1.9

2.2

ug/l

186.5

663.7

2.57

178

1445

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

513

4442

1.17

2.83

1.2

iu/ml

139.0

148.6

0.20

178

1783

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

410

4803

0.84

2.82

2.6

2.8

ng/l

129.8

178.0

3.50

381

4378

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

392

1.56

2.81

1.3

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

194

1525

1.28

2.80

3.2

1.6

ratio

1.5

1.3

0.60

140

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

103

737

1.40

2.79

1.3

1.2

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

538

1.47

2.79

2.1

1.7

32.6

32.1

0.48

532

(3014051) Protein [Presence] in Urine by Test strip

183

1431

1.29

2.76

2.3

2.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

200

1582

1.27

2.76

3.2

1.6

mg/l

59.1

39.6

0.46

157

1283

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

199

1575

1.27

2.73

3.2

1.6

mg/l

24.9

34.8

1.69

157

1270

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

187

1469

1.28

2.73

1.3

u/ml

50.4

50.3

0.00

168

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

118

2.04

2.71

2.2

2.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

170

1322

1.29

2.69

2.4

2.9

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2312

21881

1.09

2.68

4.5

4.3

—

(40768806) Pleura Pathology biopsy report

234

1.71

2.67

1.7

1.5

—

(3051611) Lipemic interference index of Serum or Plasma

519

1.47

2.66

3.0

3.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

645

1.42

2.63

1.5

—

(3006270) Folate [Moles/volume] in Blood

529

1.46

2.62

1.2

nmol/l

383.8

361.1

0.43

441

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

102

738

1.39

2.62

1.2

1.3

pmol/l

342.7

292.1

0.92

563

(3016244) Insulin [Units/volume] in Serum or Plasma

274

1.65

2.60

4.2

3.4

mu/l

28.1

25.5

0.15

263

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

200

1595

1.26

2.60

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

214

1.73

2.58

2.4

2.3

—

(3000494) Fungus identified in Specimen by Culture

712

6355

1.14

2.58

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

211

1696

1.25

2.57

1.8

1.9

iu/l

5.1

9.4

0.41

637

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

115

854

1.35

2.53

1.3

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

629

5583

1.14

2.49

1.6

1.5

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

2.20

2.47

1.4

1.3

70.3

56.4

0.85

(3015235) Bicarbonate [Moles/volume] in Capillary blood

141

1084

1.31

2.46

3.5

2.9

mmol/l

25.2

25.4

0.19

128

949

(3025941) Bacteria identified in Stool by Culture

382

3271

1.18

2.45

1.3

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

221

1796

1.24

2.45

1.7

1.5

—

(3026250) Tacrolimus [Mass/volume] in Blood

137

1.90

2.45

30.8

32.6

ug/l

7.2

7.1

0.08

122

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.24

2.43

1.2

1.6

—

(3037756) Immunofixation for Serum or Plasma

124

938

1.33

2.43

1.7

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

211

1.71

2.42

1.3

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

211

1.71

2.42

1.3

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

242

1.66

2.40

1.4

1.3

nmol/l

0.7

1.2

4.12

197

(40758292) HTLV I+II Ab panel - Serum

3.34

2.39

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

206

2529

0.81

2.37

1.4

1.5

—

(3044007) Cell count panel - Peritoneal fluid

2.21

2.37

1.9

2.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

426

3705

1.16

2.27

1.3

u/ml

122.3

179.6

2.89

395

3401

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.48

2.26

2.0

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1407

13118

1.09

2.26

1.7

pmol/l

20108179.8

34632331.0

0.57

1114

10730

(3051387) C reactive protein [Mass/volume] in Capillary blood

149

1170

1.28

2.24

4.3

3.5

mg/l

21.7

24.2

0.35

739

(3000093) Morphology [Interpretation] in Blood Narrative

366

1.51

2.24

1.1

—

(3000991) Gas panel - Venous blood

403

3497

1.16

2.22

7.1

6.7

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

279

2348

1.20

2.22

1.7

2.0

u/l

39.5

39.7

0.05

234

2082

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

194

1.70

2.22

1.2

1.3

—

(3044927) Protein electrophoresis panel - Urine

557

1.41

2.21

1.1

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

217

1.66

2.21

1.1

1.2

—

(3042631) Mycobacterium sp identified in Specimen

541

1.41

2.20

2.9

—

(40765096) Chromosome analysis panel by Banding

2.41

2.19

1.2

1.1

—

(3000012) Reticulocyte production index

272

1.58

2.19

1.7

1.4

—

(4211845)

297

1.55

2.15

3.9

3.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

198

0.40

2.15

1.0

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

3.00

2.14

1.0

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.30

2.14

1.1

1.0

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

122

941

1.30

2.12

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

122

941

1.30

2.12

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

203

1665

1.23

2.11

2.3

1.5

g/l

0.6

0.4

0.53

165

1396

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

2.05

2.11

1.8

2.0

e6/l

1443.2

41816.6

—

(3020650) Glucose [Presence] in Urine

131

1.84

2.07

1.6

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

5.00

2.07

11.0

1.0

—

(21494814) CD8 cells/100 lymphocytes in Specimen

110

1.91

2.05

2.6

1.8

—

(40760888) Immunoglobulin light chains.free panel - Serum

146

1160

1.26

2.03

3.4

1.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5537

54561

1.10

2.01

4.2

4.0

mmol/l

1.3

6.56

4906

49563

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

282

2401

1.18

2.00

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.96

1.99

2.3

1.5

—

(3010375) cycloSPORINE [Mass/volume] in Blood

155

1.74

1.99

25.5

ug/l

108.8

105.0

0.14

127

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

181

1478

1.23

1.99

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

175

1426

1.23

1.96

1.2

—

(3029937) Albumin [Presence] in Urine by Test strip

1618

15261

1.08

1.96

4.6

4.5

estimate

0.0

0.51

647

4871

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

633

0.66

1.95

1.2

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

241

1.58

1.95

1.3

1.6

—

(3011985) Renin [Units/volume] in Plasma

104

796

1.31

1.94

1.2

1.4

mu/l

33.7

56.3

1.99

711

(3023183) Ammonium ion [Moles/volume] in Plasma

744

1.32

1.94

2.5

umol/l

33.7

31.9

0.22

634

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.19

1.94

1.1

1.0

—

(21494755) Public health laboratory ask at order entry panel

367

4197

0.87

1.94

1.3

—

(4212803)

2.73

1.93

1.2

1.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

258

2192

1.18

1.89

8.2

8.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.18

1.88

2.1

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1091

0.75

1.87

1.3

1.4

—

(3036603) Volume of Urine

341

1.47

1.86

1.5

1.4

1715.9

1941.9

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

241

2040

1.19

1.85

3.6

3.8

mmol/l

24.3

24.5

0.61

222

1817

(3026692) Albumin [Mass/volume] in Peritoneal fluid

2.03

1.85

1.3

1.4

g/l

12.6

12.4

0.02

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.94

1.84

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

198

1.62

1.82

1.2

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

222

1868

1.20

1.82

2.2

1.5

g/l

9.4

10.2

2.22

176

1536

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

189

1567

1.21

1.82

2.1

1.5

g/l

37.9

37.7

0.12

153

1306

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

703

1.31

1.77

1.3

1.2

u/ml

284.3

292.9

0.11

444

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

235

1995

1.18

1.76

2.1

1.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

106

827

1.29

1.75

1.4

1.5

g/l

0.6

0.7

0.40

613

(3021788) Differential panel - Synovial fluid

139

1123

1.24

1.72

1.4

1.5

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

225

1.56

1.72

1.6

ug/l

0.4

0.20

144

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.67

1.72

2.3

2.0

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

220

1863

1.19

1.70

2.2

1.5

g/l

3.1

0.06

162

1416

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

373

1.42

1.70

2.8

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

226

1.55

1.70

1.2

1.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

234

1997

1.18

1.66

2.1

1.5

g/l

3.6

3.8

1.35

159

1385

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

234

1998

1.18

1.65

2.1

1.5

g/l

7.5

7.6

0.21

166

1436

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.80

1.65

1.4

2.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

427

1.39

1.63

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

327

1.44

1.62

1.6

1.4

umol/l

11.5

11.7

0.07

311

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

344

1.43

1.61

1.1

1.0

nmol/l

14.5

4.4

0.66

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

558

1.33

1.59

1.2

1.3

—

(3000060) B lymphocytes [#/volume] in Blood

1.95

1.59

1.2

2.2

e6/l

424.0

127.4

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

608

5547

1.11

1.58

6.1

5.5

mmol/l

104.4

103.9

1.62

595

5423

(3016502) Oxygen saturation in Arterial blood

486

4382

1.12

1.58

6.3

95.4

95.5

0.16

463

4196

(3043238) Trisomy 21 risk [Likelihood] in Fetus

519

0.67

1.56

1.2

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

338

1.42

1.56

1.4

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

338

1.42

1.56

1.4

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

338

1.42

1.56

1.4

1.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

230

1974

1.17

1.55

1.3

u/ml

56.1

45.5

0.14

135

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.43

1.53

1.4

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

715

0.73

1.53

1.4

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

257

1.48

1.52

1.9

1.5

mg/l

2.7

3.3

0.71

241

(3023511) Choriogonadotropin [Units/volume] in Urine

686

1.29

1.51

1.2

1.3

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

529

1.33

1.50

1.1

—

37.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

495

1.34

1.49

1.3

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

129

1054

1.23

1.49

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

401

1.37

1.48

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

163

1364

1.20

1.48

2.2

1.5

g/l

0.0

0.50

146

1225

(4133840)

109

1.75

1.46

1.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

343

1.40

1.46

1.1

1.5

u/l

4.8

5.6

0.92

292

(3012501) Base excess in Blood by calculation

121

986

1.23

1.44

3.5

3.4

mmol/l

2.9

2.7

0.34

684

(4094501)

180

1525

1.19

1.43

1.1

—

(1002224) Polysomnography panel

233

2019

1.16

1.41

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

631

1.29

1.41

1.1

g/l

1.5

0.20

561

(3047007) Chlamydophila sp Ab [Presence] in Serum

792

1.25

1.40

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5723

56642

1.09

1.39

4.8

4.5

mmol/l

1.6

0.94

5111

51947

(3006462) Nitrate [Presence] in Urine

279

1.44

1.39

4.0

3.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

493

0.69

1.38

1.2

1.4

—

(4024509)

704

1.27

1.38

1.7

1.6

—

(3000492) Spirometry study

547

5007

1.10

1.36

1.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

127

1.66

1.36

1.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

116

1412

0.82

1.36

3.8

4.1

mmol/l

3.9

3.8

1.01

107

1337

(3005033) Fetal Nuchal fold Thickness US

491

0.69

1.36

1.2

1.4

—

(3026726) Creatinine [Moles/volume] in Specimen

2.94

1.36

1.6

4.4

umol/l

619.2

306.8

—

(3018001) Oat IgE Ab [Units/volume] in Serum

0.00

1.34

0.0

1.0

—

0.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5765

57091

1.09

1.34

4.7

4.6

mmol/l

4.9

0.74

5193

52638

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

120

1.67

1.33

1.1

—

(3020891) Body temperature

162

1906

0.85

1.32

4.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

311

2765

1.13

1.32

1.2

1.3

u/ml

1.4

1.0

0.14

258

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.09

1.30

2.3

1.9

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

453

4120

1.11

1.30

2.4

au/ml

16.6

29.0

1.28

222

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

702

1.26

1.29

1.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

444

4036

1.11

1.28

6.7

6.6

g/l

118.7

119.7

0.57

425

3858

(3027456) Digoxin [Moles/volume] in Serum or Plasma

147

1238

1.19

1.28

3.3

nmol/l

0.8

0.56

110

985

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

589

0.73

1.28

1.2

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

310

1.39

1.27

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.94

1.27

1.0

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

588

0.73

1.27

1.2

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

587

0.73

1.26

1.2

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

587

0.73

1.26

1.2

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

174

1490

1.17

1.26

1.7

2.1

mg/l

11.1

0.03

151

1368

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

158

1343

1.18

1.25

2.2

1.5

g/l

0.0

0.00

146

1220

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

211

1.47

1.24

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

208

1808

1.16

1.24

1.3

u/ml

14.7

5.6

0.43

327

(40762814) Titanium [Mass/volume] in Blood

115

1.65

1.24

2.7

2.2

ug/l

3.2

3.5

0.20

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

221

1930

1.15

1.24

1.4

1.7

mg/l

3.3

0.02

148

1373

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.91

1.22

1.5

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

654

1.26

1.22

1.2

1.1

—

(3017569) Oxygen content in Arterial blood

212

1.46

1.22

2.1

2.3

—

(3019977) pH of Arterial blood

237

1.44

1.22

2.5

7.4

0.23

(3003129) Base excess in Capillary blood by calculation

116

1.64

1.21

2.2

1.7

mmol/l

1.9

1.3

0.19

110

(3016018) Differential panel - Cerebral spinal fluid

549

1.28

1.20

1.2

1.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

719

1.24

1.19

1.3

1.2

u/l

40.8

27.4

0.50

625

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

523

1.28

1.19

1.2

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

306

1.37

1.19

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

170

1462

1.17

1.18

2.2

1.5

g/l

0.0

0.10

152

1318

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

480

1.29

1.18

5.2

6.8

mg/l

11.8

12.4

0.51

429

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.00

1.16

2.5

3.9

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.05

1.15

2.4

2.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5869

58217

1.08

1.14

5.3

5.2

mmol/l

2.9

2.8

0.15

5265

53475

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

167

1440

1.16

1.13

1.2

—

17.8

—

(3036782) Glucose [Moles/volume] in Pleural fluid

267

1.39

1.12

1.4

1.3

mmol/l

6.8

7.0

0.19

245

(3051101) Glucose [Moles/volume] in Cord blood

114

0.44

1.12

1.8

5.7

—

(3010421) pH of Blood

139

1183

1.18

1.11

3.3

3.2

7.4

1.17

120

959

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

618

1.25

1.11

1.3

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.71

1.11

2.8

1.7

—

(3003396) Base excess in Arterial blood by calculation

539

4989

1.09

1.10

6.1

6.0

mmol/l

1.1

1.5

2.16

425

3929

(3024932) HLA-DR beta [Type]

1.67

1.10

1.2

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

2.38

1.09

2.2

2.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.19

1.08

1.4

1.5

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

540

5006

1.09

1.07

6.1

6.0

kpa

5.1

0.78

517

4755

(3000330) Specific gravity of Urine by Test strip

337

3056

1.11

1.06

3.4

3.7

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

176

1533

1.15

1.06

1.8

ug/l

0.8

2.2

3.84

147

1319

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

356

1.32

1.06

2.4

—

(3029075) Extractable nuclear Ab panel - Serum

161

1.49

1.06

1.2

1.1

—

(3027801) Oxygen [Partial pressure] in Arterial blood

539

5004

1.08

1.03

6.1

6.0

kpa

13.0

12.0

3.74

513

4749

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

358

1.32

1.03

1.5

1.4

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

402

1.30

1.03

1.1

1.0

mg/l

297.7

302.1

0.19

356

(3024471) HLA-A [Type]

1.63

1.03

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.83

1.02

1.4

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

414

4502

0.91

1.02

1.9

2.4

ug/l

6.7

5.9

0.26

327

3815

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

142

1225

1.16

0.99

1.5

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

202

1788

1.13

0.98

1.3

u/ml

1.9

5.5

1.24

211

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

119

1013

1.18

0.98

1.7

1.6

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

485

1.26

0.98

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

190

1676

1.14

0.98

1.1

u/ml

7.0

8.0

0.08

179

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1113

10617

1.06

0.98

3.4

3.7

ng/l

169.5

315.5

2.24

799

7972

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

228

2035

1.12

0.98

1.7

1.9

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

450

1.27

0.97

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

215

1.40

0.97

2.0

2.1

—

(4062490)

531

1.25

0.96

1.2

1.5

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

336

1.31

0.96

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

124

1.53

0.96

1.2

1.6

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

207

1.40

0.96

5.0

4.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

199

1.41

0.95

1.4

1.6

—

(4027681)

276

1.34

0.95

1.3

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

433

0.74

0.94

1.5

1.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

399

1.28

0.94

1.5

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1.61

0.93

1.2

1.1

—

1.3

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

2.22

0.93

2.0

2.3

mg/l

4.2

3.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

301

2738

1.10

0.93

1.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

101

854

1.19

0.92

1.1

au/ml

14.8

17.7

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

262

2892

0.90

5.8

6.4

mmol/l

24.7

24.9

0.49

246

2661

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

402

4348

0.92

0.90

2.2

2.3

ml/min/173m2

64.8

65.2

0.06

148

1733

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

709

1.20

0.90

1.2

1.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

314

2868

1.10

0.90

1.1

titre

200.6

159.8

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.75

0.90

1.8

1.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

226

2029

1.12

0.90

1.5

1.6

g/l

1.6

0.01

184

1731

(3009445) Proteinase 3 Ab [Units/volume] in Serum

256

2316

1.11

0.89

1.6

u/ml

22.5

11.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

332

3045

1.10

0.88

1.7

1.8

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

104

888

1.17

0.86

1.4

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

406

3762

1.08

0.85

1.3

au/ml

63.2

46.4

—

158

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.59

0.84

1.3

1.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

204

1830

1.12

0.84

1.5

1.7

g/l

1.2

0.14

194

1723

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

154

1.43

0.83

2.6

2.9

mg/l

8.0

7.2

0.27

123

(3037556) Urate [Mass/volume] in Serum or Plasma

154

1.43

0.83

1.1

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

121

1.49

0.82

1.5

2.6

45.8

48.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

372

1.27

0.82

1.5

g/l

33.8

29.1

1.52

319

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

717

1.19

0.82

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

105

1.53

0.81

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

355

1.27

0.81

1.1

mg/l

282.9

238.2

0.68

314

(3023410) Appearance of Cerebral spinal fluid

499

1.22

0.80

1.5

—

(4306422)

737

1.18

0.80

1.1

1.2

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.78

0.0

1.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

538

1.21

0.77

1.2

1.5

g/l

0.4

0.12

374

(3028192) IgG subclass 2 [Mass/volume] in Serum

538

1.21

0.77

1.2

1.5

g/l

2.6

2.9

0.52

373

(3027135) IgG subclass 1 [Mass/volume] in Serum

538

1.21

0.77

1.2

1.5

g/l

6.1

6.7

1.20

374

(3030981) Hyaline casts [#/volume] in Urine by Automated count

265

2423

1.10

0.77

2.7

2.4

e6/l

0.3

0.01

256

2327

(1616796) Gas panel - Central venous blood

108

935

1.16

0.77

4.0

3.3

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.77

0.0

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

200

1804

1.11

0.76

1.5

1.7

g/l

0.2

0.00

189

1702

(3022475) Manganese [Moles/volume] in Blood

1.77

0.76

1.3

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

714

0.82

0.76

1.2

1.3

mmol/l

7.1

7.5

0.41

511

(44816559) Phosphatidylethanol [Mass/volume] in Blood

835

1.16

0.75

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

149

1.41

0.75

1.2

1.1

—

(3020491) Glucose [Moles/volume] in Blood

377

1.25

0.75

4.0

1.7

mmol/l

6.4

6.9

1.74

255

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

789

1.17

0.75

1.6

52.4

54.5

0.21

485

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

1.54

0.75

1.3

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.54

0.75

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.08

0.74

7.4

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.08

0.74

1.2

1.0

—

(4010399)

472

4429

1.07

0.74

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

133

1.43

0.73

1.1

—

(3028433) Virus identified in Specimen by Culture

150

1.40

0.73

1.0

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

150

1.40

0.73

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

166

1487

1.12

0.73

1.2

1.3

u/ml

2.8

5.0

—

109

(3004616) Nuclear Ab [Presence] in Serum

838

1.16

0.73

1.2

1.3

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

125

1.44

0.72

1.9

2.5

mmol/l

7.5

7.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

618

1.18

0.70

1.1

1.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

177

1.36

0.70

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

521

0.80

0.70

1.5

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

563

5328

1.06

0.69

1.6

1.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

101

1157

0.87

0.69

2.2

2.4

ug/min

99.8

68.4

0.16

626

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.85

0.68

8.4

1.4

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

302

1.26

0.67

1.5

1.0

4.2

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

714

1.16

0.67

2.8

13.3

0.22

703

(3007566) Smooth muscle Ab [Titer] in Serum

167

1506

1.11

0.67

1.3

1.2

titre

115.0

151.8

0.34

126

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

687

1.17

0.66

1.1

iu/ml

62.5

18074.8

0.57

136

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

136

1.40

0.66

3.5

2.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

494

1.20

0.65

1.7

—

(3009508) Creatinine [Moles/volume] in Urine

1779

17328

1.04

0.65

3.0

mmol/l

6.5

6.3

0.73

1437

14516

(3035933) Granulocytes/100 leukocytes in Blood

103

1.46

0.64

1.0

2.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

313

1.25

0.64

1.5

1.8

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1801

17551

1.04

0.64

3.8

mg/mmol

5.4

7.6

1.80

965

9980

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

830

1.15

0.64

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

523

4956

1.06

0.63

1.5

1.6

1.4

0.09

441

4335

(3012516) Albumin [Mass/volume] in Urine

1711

16664

1.04

0.63

3.1

mg/l

610.1

407.6

0.65

916

9319

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

756

1.15

0.63

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

723

7556

0.95

0.63

5.7

6.4

—

(3051651) Icteric interference index of Serum or Plasma

225

1.29

0.63

3.9

3.8

—

(3019060) Gas panel - Arterial blood

280

3014

0.93

0.62

3.9

4.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

369

1.22

0.62

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

138

1.38

0.62

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

138

1.38

0.62

2.3

2.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

226

1.28

0.61

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

489

1.19

0.61

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

489

1.19

0.61

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

289

1.25

0.60

1.3

1.4

umol/l

37.3

24.3

1.20

270

(3016650) Hepatitis A virus Ab [Presence] in Serum

694

1.15

0.60

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

200

1.30

0.60

2.6

2.7

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

490

1.19

0.60

1.2

—

(3048879) Bone marrow aspiration report

105

1.43

0.60

1.3

1.5

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

148

1.35

0.59

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

148

1.35

0.59

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

148

1.35

0.59

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

148

1.35

0.59

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

272

1.25

0.59

1.4

1.8

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

302

2819

1.07

0.59

1.5

1.4

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

157

1.34

0.59

1.0

u/ml

1.0

1.3

0.11

(3038177) Helicobacter pylori Ab [Presence] in Serum

112

998

1.12

0.58

1.2

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

453

4291

1.06

0.57

3.2

3.5

kpa

5.8

5.9

0.97

442

4164

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

1.48

0.57

2.1

1.5

35.3

46.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.67

0.56

1.2

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

1.67

0.56

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.67

0.56

1.0

—

(3017509) Phencyclidine [Presence] in Urine

1.67

0.56

1.0

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

274

1.24

0.56

1.2

1.1

—

(3000285) Sodium [Moles/volume] in Blood

0.57

0.56

2.0

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

118

1058

1.12

0.55

1.2

1.4

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.62

0.55

1.0

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.54

0.55

1.9

2.8

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

430

1.19

0.55

1.4

1.2

titre

252.5

191.4

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

375

1.20

0.55

1.2

mg/l

42.9

36.4

0.22

313

(3042733) HLA Ab [Presence] in Serum

107

1.40

0.55

3.6

4.9

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

168

1.31

0.54

1.1

1.2

33.7

17.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

122

0.66

0.54

1.3

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

900

0.88

0.54

1.4

1.6

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

1.58

0.54

1.3

1.4

umol/l

0.7

0.9

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

339

3191

1.07

0.54

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1371

14082

0.97

0.54

3.7

4.0

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

487

1.17

0.54

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

487

1.17

0.54

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

777

1.13

0.54

1.1

u/ml

4.6

3.5

0.17

337

(3008536) Aspergillus sp Ab [Presence] in Serum

1.48

0.53

1.1

1.7

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

441

1.18

0.53

1.0

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

488

1.17

0.53

1.2

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.43

0.52

1.2

1.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

192

1772

1.09

0.52

1.6

iu/ml

0.1

11.5

0.68

372

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

173

1590

1.09

0.52

1.5

1.4

—

(3034426) Prothrombin time (PT)

161

1.31

0.51

1.3

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

183

1981

0.92

0.50

3.9

4.4

0.9

0.79

169

1855

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

185

2000

0.92

0.49

3.9

4.3

1.6

0.05

171

1873

(3014765) Yersinia sp identified in Stool by Organism specific culture

187

1729

1.08

0.49

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.56

0.48

1.9

2.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

108

0.65

0.48

1.0

—

(21494434) Karyotype in Bone marrow

326

1.20

0.48

1.3

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

345

1.19

0.47

1.4

e6/l

3305.5

2239.5

0.34

261

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

578

1.14

0.47

1.6

1.5

41.1

35.6

0.53

335

(40768446) Kidney Pathology biopsy report

146

1.30

0.47

1.9

1.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

793

0.88

0.46

1.1

u/ml

0.7

0.9

0.16

311

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.61

0.45

1.2

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

1.43

0.45

1.1

1.0

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

556

5339

1.05

0.45

1.6

1.7

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

468

1.16

0.45

1.7

1.6

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

147

1.29

0.45

1.0

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

127

1162

1.09

0.44

1.3

1.4

e6/l

51.2

27.3

0.36

104

915

(3034274) Bile acid [Moles/volume] in Serum --fasting

432

1.16

0.44

2.0

1.7

umol/l

9.4

7.7

0.24

309

(3011288) Drugs identified in Urine by Screen method

696

1.12

0.43

1.4

2.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

122

1.31

0.42

3.7

2.9

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

332

1.18

0.41

1.6

1.5

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

491

1.14

0.41

1.4

1.6

u/ml

20.1

23.9

—

107

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.41

0.0

1.3

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

379

1.16

0.41

1.3

1.2

u/l

94.0

75.4

0.46

329

(3002032) Base excess in Venous blood by calculation

448

4295

1.05

0.40

3.2

3.5

mmol/l

1.7

2.2

2.35

376

3560

(42529406) Shigella sp [Presence] in Stool by Culture

186

1739

1.07

0.40

1.2

—

(3022229) Phosphate [Moles/volume] in Urine

0.00

0.40

0.0

1.0

—

16.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

298

2831

1.06

0.39

1.5

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

196

1.23

0.39

1.0

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

183

1713

1.07

0.38

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

727

0.89

0.38

4.4

4.9

umol/l

342.6

373.5

0.92

622

(3028308) Erythrocytes [#/volume] in Pleural fluid

298

1.18

0.38

1.5

1.4

e6/l

127505.3

49180.9

0.31

178

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

126

1164

1.08

0.38

1.4

e6/l

1989.2

1934.4

0.01

110

968

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.32

0.37

1.3

1.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

280

1.18

0.37

1.4

2.5

u/ml

767.4

754.4

0.02

275

(3018572) Chloride [Moles/volume] in Blood

1018

0.91

0.37

4.6

5.8

mmol/l

104.8

104.5

0.17

908

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

715

1.11

0.36

1.1

126.0

121.9

0.53

637

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.29

0.36

1.1

1.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

103

945

1.09

0.36

1.8

1.7

—

(3039000) Anion gap in Blood

1017

0.91

0.36

4.6

5.8

mmol/l

10.7

11.1

0.62

907

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.27

0.36

2.4

2.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

356

1.15

0.36

2.0

1.6

—

0.6

—

(44806071)

0.66

0.35

1.2

1.1

—

(3047181) Lactate [Moles/volume] in Blood

139

1492

0.93

0.35

4.1

5.0

mmol/l

1.4

1.3

1.09

120

1313

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

432

1.14

0.35

1.3

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

126

1.27

0.35

1.1

1.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

424

1.13

0.34

1.7

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

434

1.13

0.33

1.3

1.2

—

(3022689) Creatine [Moles/volume] in Urine

188

0.80

0.33

1.2

1.6

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.69

0.33

1.7

1.8

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

444

4286

1.04

0.32

1.4

1.3

—

(44813793)

464

1.12

0.32

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

360

1.14

0.32

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

259

2714

0.95

0.32

1.5

—

(3032057) Clostridioides difficile [Presence] in Stool

128

1.25

0.31

1.5

1.6

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.32

0.30

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

829

0.92

0.30

1.1

u/ml

1.7

2.9

1.09

387

(3035947) Staphylolysin Ab [Units/volume] in Serum

212

1.18

0.30

1.2

1.1

iu/ml

—

3.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

297

1.15

0.29

1.0

u/ml

0.6

1.4

0.37

(3008116) Ketones [Moles/volume] in Urine by Test strip

109

0.73

0.29

1.3

1.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

375

3620

1.04

0.28

2.6

2.9

kpa

4.8

4.5

1.38

362

3512

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

204

1.18

0.28

1.1

ng/l

96.2

231.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

129

0.77

0.28

1.3

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

158

1.20

0.28

1.2

1.4

—

618543.8

—

(44806118)

407

0.88

0.27

1.2

1.4

—

(44790047)

407

0.88

0.27

1.2

1.4

—

(44790049)

407

0.88

0.27

1.2

1.4

—

(44790048)

407

0.88

0.27

1.2

1.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

116

0.78

0.27

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

246

0.85

0.26

1.2

—

(3008898) HLA-B27 [Presence]

204

1949

1.05

0.26

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

127

0.79

0.25

1.3

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

550

0.91

0.25

1.2

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

518

0.91

0.24

1.1

u/ml

0.3

0.4

0.06

109

(3047189) Immunofixation for 24 hour Urine

142

1.20

0.24

1.7

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

283

1.13

0.24

1.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

191

1826

1.05

0.24

1.7

titre

113.3

329.0

—

111

(3024891) Influenza virus A+B Ag [Presence] in Specimen

126

1191

1.06

0.24

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

369

1.11

0.24

1.7

1.5

u/l

2.8

6.8

1.84

173

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

286

0.87

0.23

1.5

1.9

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

152

1.18

0.23

1.1

umol/24h

1.7

0.7

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

124

1174

1.06

0.23

1.3

mmol/l

3.7

0.27

116

1103

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

136

0.81

0.23

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.76

0.22

1.1

2.0

umol/l

15.3

17.8

—

(3024928) Oxygen saturation in Venous blood

102

961

1.06

0.22

2.7

3.2

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

1.22

0.22

3.4

1.7

0.6

0.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

576

0.92

0.22

1.2

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

178

0.84

0.22

1.2

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

286

1.12

0.21

1.0

u/ml

1.8

0.7

0.33

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

526

1.08

0.21

1.1

85.2

93.3

2.06

490

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

107

1.22

0.21

1.4

1.2

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

427

4161

1.03

0.21

1.7

—

(3006969) Lambda light chains [Mass/volume] in Urine

0.00

0.21

0.0

1.1

—

0.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

667

0.93

0.20

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

232

2402

0.96

0.20

2.8

3.1

mmol/l

25.7

25.6

0.24

226

2327

(3034614) HLA Ag [Interpretation]

0.00

0.20

0.0

1.1

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.3

—

116.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

139

1455

0.95

0.20

1.2

1.3

miu/ml

198.8

226.5

0.47

696

(3001729) Color of Synovial fluid

1.22

0.20

3.0

1.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

113

0.80

0.20

1.0

1.1

—

(3004775) Volume in Urine collected for unspecified duration

386

0.91

0.20

1.8

2.3

593.8

634.6

0.28

276

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

937

1.06

0.19

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

144

0.83

0.19

1.1

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

665

0.93

0.19

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

186

0.86

0.19

2.2

1.6

ug/l

9.6

8.6

0.25

186

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.23

0.18

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

259

0.89

0.18

15.2

10.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

628

1.07

0.18

1.2

u/l

58.5

58.6

0.01

422

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

309

1.10

0.18

1.3

2.0

u/field

2.4

2.2

0.06

195

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.19

0.18

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.19

0.18

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

867

0.95

0.18

1.4

1.6

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

119

1.18

0.17

1.1

—

(3023419) Bacteria identified in Sputum by Culture

600

1.07

0.17

2.7

2.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

195

0.87

0.17

1.3

1.2

—

(3003181) Sodium [Moles/volume] in Urine

114

1089

1.05

0.17

1.3

1.4

mmol/l

58.7

62.8

0.66

873

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.22

0.17

5.6

8.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.76

0.17

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.76

0.17

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.76

0.17

1.0

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

330

1.09

0.16

1.1

u/ml

10.2

5.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

417

1.08

0.16

2.5

—

(3025130) Human papilloma virus identified in Specimen

101

963

1.05

0.16

1.6

1.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

152

1578

0.96

0.16

1.9

1.8

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

139

1336

1.04

0.16

1.3

mg/l

485.0

513.0

0.28

129

1261

(3010726) Horse dander IgE Ab [Units/volume] in Serum

721

0.94

0.16

1.1

u/ml

1.1

1.4

0.14

158

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

267

0.90

0.16

1.2

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

443

0.92

0.16

3.8

3.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

120

1.17

0.16

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

298

0.91

0.16

1.0

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.11

0.16

1.3

1.1

umol/24h

1.5

1.6

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.13

0.15

1.4

3.0

u/field

0.7

0.9

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

461

0.93

0.14

1.0

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

809

0.95

0.14

1.3

1.7

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

223

0.90

0.14

1.2

1.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

685

6753

1.02

0.14

23.8

24.7

inr

1.3

0.41

102

966

(1761482) Bacteria [#/volume] in Urine by Culture

144

1489

0.97

0.14

4.3

4.9

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

634

0.95

0.14

1.1

u/ml

4.4

2.9

0.25

226

(3035880) pH of Pleural fluid

160

1.13

0.14

1.3

1.2

—

(3011648) Oxygen content in Venous blood

363

1.07

0.13

2.4

2.2

10.3

11.0

0.52

363

(3027944) Amphetamines [Presence] in Urine

1031

0.96

0.13

1.3

1.7

—

(3000764) Benzodiazepines [Presence] in Urine

100

1041

0.96

0.13

1.3

1.7

—

(3045788) Cell count panel - Pleural fluid

276

1.09

0.13

1.5

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

561

0.94

0.13

1.2

u/ml

23.6

46.9

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

657

1.05

0.13

2.2

2.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

335

0.92

0.13

1.3

1.4

—

(3002619) Bacteria identified in Specimen by Culture

117

0.85

0.13

1.0

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

277

1.08

0.12

1.3

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

472

1.06

0.12

1.3

u/ml

1.5

1.2

0.13

220

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

287

1.08

0.12

1.2

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

171

1.11

0.12

1.2

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

156

1515

1.03

0.12

1.6

e6/l

11547.7

12577.8

0.12

113

1104

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

179

0.89

0.12

1.1

1.5

mmol/l

10.2

8.3

—

109

(3028300) Cannabinoids [Presence] in Urine

101

1048

0.96

0.12

1.3

1.7

—

(3024263) Appearance of Synovial fluid

303

0.92

0.12

2.4

1.7

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

627

6191

1.01

0.11

1.6

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

425

0.94

0.11

1.0

ng/l

45.1

46.7

0.06

277

(4015189)

153

1.11

0.11

2.6

2.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

769

1.04

0.11

1.3

1.2

u/ml

4.1

3.9

0.02

271

(3027231) Wheat IgE Ab [Units/volume] in Serum

105

1.14

0.11

1.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

188

0.90

0.11

1.7

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

188

0.90

0.11

1.7

1.4

—

(3038515) Glucose [Moles/volume] in Venous blood

107

1105

0.97

0.10

2.9

3.2

mmol/l

7.1

7.5

1.08

107

1077

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

270

1.07

0.10

1.1

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

249

0.92

0.10

1.2

1.4

nmol/l

129.1

133.9

0.26

249

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

106

1.13

0.09

1.1

—

(40762365) Oxygen content in Arterial blood by calculation

1.09

0.09

2.0

2.3

ml/dl

15.5

15.3

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

422

0.95

0.09

1.0

ng/l

683.6

697.9

0.07

265

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

207

0.92

0.09

3.3

2.8

umol/l

32.8

27.0

1.37

154

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.06

0.09

2.2

1.9

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

330

1.06

0.09

1.4

1.3

—

(3009871) Measles virus Ab [Titer] in Serum

176

0.91

0.09

1.9

1.8

—

(3041354) Potassium [Moles/volume] in Venous blood

665

1.04

0.09

2.2

2.3

mmol/l

4.0

0.74

660

(3035285) Chloride [Moles/volume] in Venous blood

665

1.04

0.09

2.2

2.3

mmol/l

105.9

105.7

0.12

660

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

0.82

0.08

1.4

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.82

0.08

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

521

0.96

0.08

2.7

2.8

mg/l

30.9

39.2

0.18

341

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

409

0.95

0.08

1.4

1.3

mmol/l

13.4

11.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

244

1.07

0.08

1.2

1.5

pmol/l

16.8

15.8

0.44

201

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

205

1.07

0.07

1.2

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

347

0.95

0.07

1.0

—

(3017704) Immunofixation for Urine

245

1.06

0.07

2.2

1.2

—

(3018133) Calcium [Moles/volume] in Urine

0.82

0.07

2.3

1.6

mmol/l

2.2

2.8

—

(3044941) Cell count panel - Synovial fluid

966

1.03

0.07

1.5

1.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

265

1.06

0.07

1.0

—

(3027008) Opiates [Presence] in Urine

102

1044

0.98

0.06

1.3

1.7

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.84

0.06

1.5

1.6

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

132

0.91

0.06

1.1

1.4

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

417

0.96

0.06

1.0

ng/l

370.3

365.4

0.03

277

(3004451) EKG impression Narrative

236

1.06

0.06

1.3

—

(3016879) Cocaine [Presence] in Urine

952

0.98

0.06

1.3

1.8

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

203

0.94

0.06

1.4

1.1

—

(3016750) Collection duration of Urine

276

1.05

0.06

1.5

2.3

min

464.5

503.4

0.99

217

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

243

0.95

0.05

1.8

2.0

ug/l

24.3

192.9

0.81

226

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

192

0.94

0.05

2.2

2.1

umol/l

52.8

57.1

0.23

145

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

919

0.98

0.05

1.1

u/ml

0.6

1.0

0.74

332

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

222

0.95

0.05

1.1

miu/ml

1439.2

1581.7

0.27

222

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

171

0.94

0.05

1.4

2.0

mg/l

6.8

10.1

—

141

(4268621)

525

1.03

0.05

2.3

2.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

130

0.92

0.04

1.3

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

118

1163

1.01

0.04

3.4

2.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

281

0.96

0.04

1.1

1.2

—

(3008295) Osmolality of Serum or Plasma

532

0.98

0.03

1.3

1.5

mosm/kgh2o

277.5

273.0

0.68

403

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

270

1.04

0.03

1.0

1.1

u/l

1.0

1.1

—

123

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

122

1.07

0.02

1.1

—

(3016038) Potassium [Moles/volume] in Urine

410

0.98

0.02

1.1

mmol/l

32.3

32.9

0.06

328

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

128

0.94

0.02

1.3

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

138

0.94

0.02

1.6

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

281

1.03

0.02

1.2

1.5

nmol/l

1.1

1.3

0.22

227

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

233

2345

0.99

0.02

2.4

2.7

1.1

1.2

0.51

233

2332

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

750

0.99

0.02

1.3

1.2

u/ml

2.6

4.2

1.90

305

(3028707) Methadone [Presence] in Urine by Screen method

481

1.02

0.02

1.3

2.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

571

1.02

0.02

1.5

1.4

e6/l

116404.6

116244.5

0.00

396

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

312

1.03

0.01

1.1

ratio

1.0

1.1

0.17

114

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

123

1.06

0.01

1.2

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

472

1.02

0.01

1.4

1.2

—

(3008037) Lactate [Moles/volume] in Venous blood

116

1151

1.01

0.01

2.8

3.1

mmol/l

1.4

1.5

0.50

116

1122

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

978

0.99

0.01

2.0

1.7

nmol/l

0.9

0.8

0.94

814

(3022493) Free Hemoglobin [Mass/volume] in Plasma

172

0.99

0.00

1.0

4.8

mg/l

59.4

63.9

—

113

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

233

0.99

0.00

1.4

1.7

umol/l

62.6

114.5

1.91

130

(3015076) Soybean IgE Ab [Units/volume] in Serum

236

1.02

0.00

1.0

u/ml

0.3

0.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

375

0.99

0.00

1.1

iu/ml

5.5

9.8

—

(3036670) Protein [Mass/volume] in Synovial fluid

188

1.01

0.00

1.3

g/l

39.9

38.6

—

104

(44806420)

162

0.99

0.00

2.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

589

1.00

0.00

1.1

u/ml

2.3

3.0

0.23

212

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

130

1.00

0.00

1.2

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

500

1.00

0.00

1.9

2.3

u/field

4.7

2.3

1.21

179

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

230

2304

1.00

0.00

2.4

2.6

0.7

0.25

222

2198

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

118

1.02

0.00

1.2

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

331

1.00

0.00

1.2

1.3

—

(3025577) Chromium [Mass/volume] in Blood

367

1.01

0.00

2.3

2.1

ug/l

1.9

2.8

1.78

319

(3017817) Protein [Mass] in Urine collected for unspecified duration

351

1.00

0.00

1.5

1.8

—

(4198724)

126

1.03

0.00

1.0

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

121

0.99

0.00

1.2

1.1

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.0

5.3

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

0.88

0.00

1.3

1.2

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

(3013762) Body weight Measured

0.00

0.0

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.99

0.00

11.4

7.7

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

0.0

1.0

—

0.2

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.1

—

2.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.0

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.95

0.00

1.5

2.9

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.2

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

7.7

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

1.4

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.2

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

1.3

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.1

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.97

0.00

12.9

7.6

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.99

0.00

1.3

1.2

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

0.99

0.00

2.3

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.4

—

(3044009) aPTT.lupus sensitive (LA screen)

0.93

0.00

1.2

1.3

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

118.6

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

4.6

—

1.6

—

(3008717) Parietal cell Ab [Titer] in Serum

0.00

0.0

1.0

—

474.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.88

0.00

1.0

1.1

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.0

1.0

—

19.2

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.3

—

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.86

0.00

1.2

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.4

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.2

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.6

—

1184.3

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: CD2_LEIOMYOMA_ENDOMETRIOSIS_EXALLC – Benign leiomyoma with endometriosis

GWS hits: 12

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Benign leiomyoma with endometriosis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints